{"study_id": 86203, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 80, "study_goal": "The researchers aimed to determine if increased oily fish intake during pregnancy alters fatty acid concentrations in plasma phosphatidylcholine (PC) and affects in vivo PGF(2\u03b1) formation.", "results_summary": "The study found that oily fish intake increased eicosapentaenoic and docosahexaenoic acids while decreasing arachidonic acid in plasma PC, but it did not affect urinary PGF(2\u03b1) metabolite concentrations. The increase in PGF(2\u03b1) metabolite concentrations during pregnancy was observed in both groups.", "population_specificity": "British pregnant women", "effective_dosage": "Two portions of farmed salmon weekly", "study_duration": "From pregnancy week 20 until parturition", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:09.131726+00:00"}
{"study_id": 86204, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to review the nature of oxidized LDL (Ox-LDL), including phosphatidylcholine (PtdCho), and discuss potential challenges in inhibiting its formation.", "results_summary": "The abstract highlights that Ox-LDL, containing PtdCho, is implicated in atherosclerosis, but clinical trials with antioxidants like \u03b1-tocopherol have failed to show benefits. The exact mechanisms and effects of Ox-LDL in vivo remain unclear.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not available.", "study_duration": "Not applicable (review study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:09.831621+00:00"}
{"study_id": 86172, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the functional and structural characteristics of apoA-I from human, bovine, and porcine sources, focusing on their antioxidant ability, protein stability, and interaction with phosphatidylcholine.", "results_summary": "Bovine apoA-I showed weaker binding to dimyristoyl phosphatidylcholine but formed larger rHDL particles with palmitoyl oleoyl phosphatidylcholine. Bovine apoA-I also exhibited greater resistance to denaturation and glycation, and more effectively inhibited LDL oxidation and macrophage uptake compared to human or porcine apoA-I.", "population_specificity": "In vitro study (no human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:10.345806+00:00"}
{"study_id": 86205, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the role of phosphatidylcholine-specific phospholipase C (PC-PLC) in atherosclerosis progression and its potential as a therapeutic target.", "results_summary": "The study found that PC-PLC contributes to endothelial dysfunction and inflammation, key factors in atherosclerosis progression, suggesting that pharmacological blockade of PC-PLC could be a viable therapeutic approach.", "population_specificity": "Not specified (likely preclinical or in vitro study based on abstract).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:10.634446+00:00"}
{"study_id": 86209, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the lateral structure and molecular organization of various clinical surfactants, including phosphatidylcholine-based formulations, to understand their differences and potential clinical implications.", "results_summary": "The study found significant differences in the structure and organization of animal-derived clinical surfactants, with all assuming a similar multilayer structure of fluid phospholipids attached to a DPPC-enriched monolayer at physiologically relevant surface pressures. These differences were linked to DPPC and cholesterol content.", "population_specificity": "Not specified (study focused on in vitro characterization of surfactant preparations).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:13.660619+00:00"}
{"study_id": 86206, "supplement_id": 1440, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and lipolytic potential of phosphatidylcholine/deoxycholic acid in mesotherapy for body contouring.", "results_summary": "Group 1 (phosphatidylcholine/deoxycholic acid) showed the highest average circumference reduction (4.41 cm per site) and weight loss (5.33 kg), with 96% of patients experiencing circumference loss and 98.7% showing a decrease in body fat percentage. No serious side effects were reported.", "population_specificity": "75 women with a mean age of 33 years.", "effective_dosage": "Not specified (administered in 15 weekly treatments).", "study_duration": "15 weeks (once weekly treatments).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:13.789337+00:00"}
{"study_id": 86207, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy, tolerability, and safety of a 4% nicotinamide-phospholipidic (N-PHCL) emulsion compared to 1% topical clindamycin phosphate for treating acne.", "results_summary": "The 4% N-PHCL cosmetic treatment was slightly superior to topical clindamycin in all studied parameters, showing better compliance and global clinical improvement. The combination of phosphatidylcholine and nicotinamide effectively normalized follicular hyperkeratinization and provided anti-inflammatory effects.", "population_specificity": "Patients with acne (specific demographics not detailed in the abstract).", "effective_dosage": "4% N-PHCL emulsion applied once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:13.945534+00:00"}
{"study_id": 86208, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the metabolism of methionine, a precursor for phosphatidylcholine synthesis, in subjects with NASH to understand potential metabolic perturbations.", "results_summary": "The study found that subjects with NASH had significantly lower rates of methionine transmethylation and SAM synthesis, suggesting impaired phosphatidylcholine production, but no difference in trans-sulfuration rates. The results indicate metabolic dysfunction in NASH that may affect phosphatidylcholine-dependent processes like VLDL export.", "population_specificity": "Clinically stable, biopsy-confirmed subjects with non-alcoholic steatohepatitis (NASH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:15.256775+00:00"}
{"study_id": 86210, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the biochemical and genetic characterization of phosphoethanolamine N-methyltransferases (PMTs) and their role in phosphatidylcholine synthesis, as well as their potential as therapeutic targets and in bioengineering.", "results_summary": "The study found that PMTs play a crucial role in the synthesis of phosphatidylcholine, impacting growth and development in various eukaryotes, and may serve as targets for therapies against parasitic infections and bioengineering stress-resistant plants.", "population_specificity": "Nematodes, plants, African clawed frogs, zebrafish, Florida lancelet, Proteobacteria, and human malaria parasites.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:18.205941+00:00"}
{"study_id": 86212, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the mechanisms by which phosphatidylcholine (PC) exerts anti-inflammatory effects and enhances surface hydrophobicity in ulcerative colitis (UC).", "results_summary": "The study found that PC reduces inflammatory activity in UC by increasing mucus hydrophobicity and inhibiting pro-inflammatory pathways (e.g., TNF-\u03b1-induced responses, MAP kinases, NF-\u03baB). Other phospholipids showed no similar effects.", "population_specificity": "Ulcerative colitis patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:18.393207+00:00"}
{"study_id": 86211, "supplement_id": 1440, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the long-term efficacy and safety of Meriva (a curcumin-phosphatidylcholine complex) in managing osteoarthritis symptoms and inflammatory markers.", "results_summary": "The study found significant improvements in clinical outcomes (WOMAC score, Karnofsky Performance Scale, treadmill walking) and inflammatory markers (IL-1beta, IL-6, sCD40L, sVCAM-1, ESR) compared to the control group, with excellent tolerability.", "population_specificity": "100 osteoarthritis patients.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Eight months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:18.936205+00:00"}
{"study_id": 86213, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to compare the hepatoprotective effects of Phosphatidylcholine (PC) with a newly designed bile acid-phospholipid conjugate (UDCA-LPE) and ursodeoxycholic acid (UDCA) in mitigating TNF\u03b1-induced liver injury.", "results_summary": "The study found that PC failed to show protective effects against TNF\u03b1-induced apoptosis and inflammation in hepatocytes or in a mouse model of acute liver injury, unlike UDCA-LPE, which demonstrated significant efficacy.", "population_specificity": "Embryonic human hepatocyte cell line CL48, primary human hepatocytes, and C57BL/6 mice.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:19.492456+00:00"}
{"study_id": 86215, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether delayed-release oral phosphatidylcholine (rPC) could effectively treat ulcerative colitis by substituting deficient PC in colonic mucus.", "results_summary": "In non-steroid-treated active UC, 53% of rPC-treated patients achieved remission compared to 10% on placebo (p < 0.001). In steroid-dependent UC patients, 50% of rPC-treated patients achieved steroid withdrawal and remission or clinical response, versus 10% on placebo (p = 0.002).", "population_specificity": "Patients with active ulcerative colitis (non-steroid-treated and steroid-dependent).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:22.897541+00:00"}
{"study_id": 86214, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to understand the role of Phosphatidylcholine in masking bile acid toxicity and preventing inflammatory liver injury and liver cancer.", "results_summary": "The study found that MDR3/Mdr2 secretes Phosphatidylcholine in coordination with bile acid secretion to reduce bile acid toxicity, and defects in these transporters can lead to severe liver diseases. Alternative transport systems in mice may offer protective mechanisms not fully utilized in humans.", "population_specificity": "Mice (bsep-/-) and implications for humans with bile acid transport defects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:23.035579+00:00"}
{"study_id": 86217, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical efficacy of a proprietary curcumin-phosphatidylcholine complex (Meriva\u00ae) in managing osteoarthritis symptoms and inflammatory markers.", "results_summary": "The study found significant improvements in WOMAC scores (58% reduction), walking distance (76 m to 332 m), and CRP levels (168 to 11.3 mg/L) in the treatment group compared to minimal improvements in controls. Treatment costs were also reduced in the intervention group.", "population_specificity": "50 patients with osteoarthritis", "effective_dosage": "200 mg curcumin per day (as part of the Meriva\u00ae complex)", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:24.577479+00:00"}
{"study_id": 86216, "supplement_id": 1440, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the upper GI damage caused by low-dose aspirin versus aspirin-phosphatidylcholine complex (PL2200) in at-risk subjects to determine if PL2200 reduces mucosal damage.", "results_summary": "PL2200 significantly reduced the incidence of multiple erosions and/or ulcers (22.2% vs. 42.2% with aspirin) and gastroduodenal ulcers (5.1% vs. 17.6% with aspirin), demonstrating superior GI protection. The study suggests PL2200 may be a safer alternative to traditional aspirin for at-risk patients.", "population_specificity": "Healthy subjects aged 50-74 years at risk of aspirin-induced ulcers.", "effective_dosage": "325 mg once daily, immediate release.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:24.648725+00:00"}
{"study_id": 86219, "supplement_id": 1440, "safety_score": "80", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Lipostabil (containing Phosphatidylcholine) is effective for reducing lower eyelid fat pads compared to a saline placebo.", "results_summary": "The study found no observable difference between Lipostabil and saline-injected eyelids, with no improvement in appearance or reduction of fullness after multiple injections. Masked observers could not distinguish treated from untreated eyelids or pre- from post-treatment pictures.", "population_specificity": "Healthy adults over 25 years with full lower eyelids, excluding those with bleeding disorders or addiction to antiwrinkle products.", "effective_dosage": "0.5 ml per eyelid (single injection).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:27.455609+00:00"}
{"study_id": 86221, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the protective role of Phosphatidylcholine (PC) in the gastrointestinal barrier and its potential therapeutic effects in ulcerative colitis.", "results_summary": "The study found that therapeutic addition of PC alleviated inflammatory activity in ulcerative colitis patients, suggesting its role in maintaining surface hydrophobicity and modulating mucosal signaling. The abstract also highlights PC's potential integration into enterocyte membranes and its regulatory impact on inflammatory pathways.", "population_specificity": "Patients with ulcerative colitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:27.761784+00:00"}
{"study_id": 86218, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether liposomal bovine lactoferrin (L-bLF) containing soy phosphatidylcholine could effectively treat periodontal disease by reducing inflammation and improving clinical markers.", "results_summary": "L-bLF supplementation significantly reduced probing depth (PD) and MCP-1 levels in gingival crevicular fluid (GCF), as well as LPS-induced cytokine production from PBMCs, but did not significantly affect BOP, GCF volume, or other cytokine levels. TLR2 and TLR4 expressions remained unchanged.", "population_specificity": "Twelve subjects with periodontal disease (multiple sites of >3 mm PD), with detailed analysis of 51 sites from five subjects.", "effective_dosage": "180 mg bLF/day in tablet form.", "study_duration": "Four weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:28.457821+00:00"}
{"study_id": 86220, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the pathways and mechanisms of glycerophospholipid synthesis, including phosphatidylcholine, in Plasmodium parasites during different developmental stages.", "results_summary": "The study found that Plasmodium parasites utilize diverse pathways for glycerophospholipid synthesis, including prokaryotic and eukaryotic-type mechanisms, with marked differences in phosphatidylcholine and phosphatidylethanolamine synthesis between species. It also highlighted gaps in knowledge about lipid acquisition at non-erythrocytic stages.", "population_specificity": "Plasmodium parasites (malaria-causing organisms)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:28.833942+00:00"}
{"study_id": 86222, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether polyene phosphatidylcholine capsule, compared to Xuezhikang Capsule, could reduce serum inflammatory factors (TNF-alpha and IL-6) in patients with NAFLD and hyperlipidemia.", "results_summary": "Both treatments significantly reduced TNF-alpha and IL-6 levels, but no significant difference was found between the two treatments at any time point. The study concluded that both interventions had anti-inflammatory effects.", "population_specificity": "84 patients with nonalcoholic fatty liver disease (NAFLD) and hyperlipidemia.", "effective_dosage": "Not specified", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:31.829750+00:00"}
{"study_id": 86223, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the role of ABCB4 gene defects (affecting MDR3 protein function) in liver diseases related to phosphatidylcholine deficiency and the therapeutic outcomes of UDCA treatment.", "results_summary": "The study found that ABCB4 mutations lead to low biliary phosphatidylcholine levels, causing severe liver diseases like PFIC3, and that UDCA therapy is effective for most patients, though some require liver transplantation.", "population_specificity": "Pediatric and adult patients with liver diseases linked to ABCB4 mutations (e.g., PFIC3, intrahepatic cholestasis of pregnancy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:31.927110+00:00"}
{"study_id": 86224, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of phospholipases A2 (PLA2), particularly PAF-AH and PLA2GX, in atherosclerosis and their interaction with phosphatidylcholine in LDL and HDL.", "results_summary": "The study found that PAF-AH activity is higher in hypercholesterolemic patients and reduced with hypolipidemic therapy, while PLA2GX efficiently hydrolyzes phosphatidylcholine in LDL, contributing to macrophage-foam cell formation. A rare polymorphism (Arg38Cys) in PLA2GX was identified but showed no association with cardiovascular risk factors.", "population_specificity": "Human subjects, particularly hypercholesterolemic patients and participants in the AtheroGene study.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:34.672712+00:00"}
{"study_id": 86225, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the role of sPLA(2)-IIA, particularly its interaction with phosphatidylcholine, in host defense against bacterial infections and its potential as a therapeutic agent.", "results_summary": "The study found that sPLA(2)-IIA exhibits potent bactericidal properties, especially against Gram-positive bacteria, due to its preference for anionic phospholipids like phosphatidylglycerol. It was less effective on host cell membranes and surfactant, which are rich in phosphatidylcholine. Recombinant sPLA(2)-IIA protected mice from pulmonary anthrax, even when bacteria down-regulated endogenous sPLA(2)-IIA expression.", "population_specificity": "Mice (transgenic and wild-type) and bacterial strains (Staphylococcus aureus, Escherichia coli, Bacillus anthracis, Bordetella pertussis).", "effective_dosage": "1.1 ng/ml (effective concentration for killing Gram-positive bacteria).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:36.076713+00:00"}
{"study_id": 86226, "supplement_id": 1440, "safety_score": "85", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to compare the therapeutic effect and safety of Qianggan Capsule (QGC) versus polyene phosphatidylcholine capsule (PPC) in treating non-alcoholic fatty liver disease (NAFLD).", "results_summary": "PPC showed modest improvements in ALT levels and CT liver/spleen ratio, but the changes were not statistically significant (P>0.05). No severe adverse reactions were reported.", "population_specificity": "88 patients with NAFLD (43 treated with PPC).", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:36.353782+00:00"}
{"study_id": 86227, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of parenteral fish oil (containing phosphatidylcholine) on plasma fatty acids, inflammatory mediators, and clinical outcomes in septic ICU patients.", "results_summary": "Fish oil increased eicosapentaenoic acid in plasma phosphatidylcholine, reduced IL-6, and improved gas exchange, with a trend toward shorter hospital stays, though ventilation days, ICU stay, and mortality were unchanged.", "population_specificity": "ICU patients with systemic inflammatory response syndrome or sepsis requiring parenteral nutrition.", "effective_dosage": "50:40:10 mixture of medium-chain fatty acids, soybean oil, and fish oil (specific dosage not detailed).", "study_duration": "5 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:37.047733+00:00"}
{"study_id": 86228, "supplement_id": 1440, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of neutral 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC) based nanoliposomes for systemic siRNA delivery in cancer therapy.", "results_summary": "The study found that DOPC-based nanoliposomes were safe and significantly more effective (10- and 30-fold) than cationic liposomes and naked siRNA, respectively, for systemic siRNA delivery to tumor tissues in murine models.", "population_specificity": "Murine (mouse) tumor models.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:37.390276+00:00"}
{"study_id": 86229, "supplement_id": 1440, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the most effective dose of delayed-release phosphatidylcholine (rPC) with the least adverse events for treating chronic-active ulcerative colitis.", "results_summary": "The study found that rPC doses \u22651 g/day significantly improved clinical activity and remission rates, with 3 g and 4 g doses being superior. Adverse events included bloating (40% of patients) and nausea (30% in the 4 g group).", "population_specificity": "Patients with nonsteroid-treated, chronic-active ulcerative pancolitis (clinical and endoscopic activity index \u22657).", "effective_dosage": "0.5 g, 1 g, 3 g, and 4 g daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:37.879978+00:00"}
{"study_id": 86230, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 55, "study_goal": "The researchers aimed to investigate the metabolic effects of functional dyspepsia (FD) and the impact of acupuncture on plasma metabolites, including phosphatidylcholine (PtdCho).", "results_summary": "The study found higher levels of phosphatidylcholine (PtdCho) in FD patients compared to healthy controls. Acupuncture treatment slightly altered lipid levels, including PtdCho, towards those of healthy controls, suggesting a potential therapeutic effect.", "population_specificity": "Six female FD patients and six female healthy control subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:39.837173+00:00"}
{"study_id": 201493, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers sought to determine whether fetal DHA inadequacy has lasting effects on child neurodevelopment into early childhood.", "results_summary": "No significant differences were found in neurodevelopment test scores between children from maternal placebo and DHA groups, but maternal DHA status was positively related to child performance on some tests, including language and short-term memory. Child DHA intake and status were also linked to maternal intake and status during gestation.", "population_specificity": "Pregnant women and their children (5-6 years old).", "effective_dosage": "400 mg/d DHA during pregnancy.", "study_duration": "Duration of pregnancy (exact length not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:43.955449+00:00"}
{"study_id": 31767, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Phosphatidylserine-decorated nanoparticles could enhance anti-inflammatory effects and macrophage targeting for acute lung injury therapy.", "results_summary": "PtdSer-decorated nanoparticles showed increased anti-inflammatory properties and macrophage phagocytosis in vitro, and in vivo studies demonstrated reduced lung inflammation and alleviated ALI symptoms.", "population_specificity": "Preclinical study (in vitro macrophages and in vivo ALI models).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:44.051189+00:00"}
{"study_id": 31766, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 50, "study_goal": "The researchers aimed to investigate the association between anti-phosphatidylserine/prothrombin complex antibodies (aPS/PT) and vertebral artery dissection in a patient with systemic lupus erythematosus (SLE).", "results_summary": "The study reported a rare case of SLE with sole positive aPS/PT results complicated by vertebral artery dissection. Treatment with methylprednisolone, prednisolone, and cyclophosphamide improved the patient's condition without sequelae.", "population_specificity": "A 44-year-old woman with SLE and a history of moyamoya vessels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:44.513267+00:00"}
{"study_id": 86231, "supplement_id": 1440, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to compare the biochemical alterations, including changes in phosphatidylcholine levels, in MCF7 breast carcinoma cells exposed to high and low doses of docetaxel.", "results_summary": "The study found a significant decrease in phosphatidylcholine levels at both high (x 0.3) and low (x 0.2) doses of docetaxel, with no significant difference between doses. The decrease was part of broader metabolic disruptions, including alterations in lipid metabolism and glutathione pathways.", "population_specificity": "Human MCF7 breast carcinoma cells (in vitro study).", "effective_dosage": "High dose (5 \u00b5M) and low dose (1 nM) of docetaxel.", "study_duration": "Up to 72 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:45.179017+00:00"}
{"study_id": 31768, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the reversibility and translational potential of Phosphatidylserine (PS) exposure in damaged cells after stroke and the role of Annexin V and Tmem30a in mitigating PS exposure and neurological impairments.", "results_summary": "The study found that Annexin V treatment reduced PS exposure and improved neurological outcomes in transient ischemia/reperfusion models but not in permanent ischemia. Tmem30a was identified as essential for reducing PS exposure and improving neurological function in the ischemic penumbra after stroke.", "population_specificity": "Patients with salvage penumbra after endovascular therapy, transient ischemia/reperfusion mouse models, and nonhuman primate ischemia/reperfusion models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:46.972131+00:00"}
{"study_id": 31770, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to investigate the prognostic and predictive potential of blood circulating endothelial cells (CECs) and related subsets in patients with metastatic colorectal cancer, not specifically Phosphatidylserine.", "results_summary": "The study found that a high percentage of annexin V-negative cells in a CD34+/CD45dim/CD117+ progenitor population correlated with reduced treatment response and worse survival, and increased concentrations of these cells were observed in patients with more metastatic sites.", "population_specificity": "Patients with metastatic colorectal cancer (n = 40).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:47.234574+00:00"}
{"study_id": 31769, "supplement_id": 1441, "safety_score": "85", "efficacy_score": 78, "quality_score": 82, "study_goal": "The researchers aimed to investigate Phosphatidylserine (PS) as a target antigen for chimeric antigen receptor T cell (CAR-T) therapy, focusing on its potential to enhance antitumor immune responses.", "results_summary": "The study found that PS-targeting CAR-T cells effectively recognized and killed PS+ tumor cells in vitro and in vivo, though fratricide during T-cell activation posed a challenge. Optimizing CAR expression or using dasatinib mitigated fratricide, enabling successful Anxa CARLow-T cell production with antitumor activity and no observed toxicity.", "population_specificity": "Murine models of PS+ hepatocarcinoma and teratocarcinoma, and various tumor cell lines and cancer tissues.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:47.314899+00:00"}
{"study_id": 31771, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether DPPS (a form of phosphatidylserine) could enhance targeted drug delivery to macrophages via inhalable microparticles.", "results_summary": "The study found that DPPS significantly increased macrophage uptake of microparticles compared to non-DPPS controls, demonstrating macrophage-specific uptake and pH-responsive release for pulmonary delivery.", "population_specificity": "RAW 264.7 macrophages (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:47.440200+00:00"}
{"study_id": 31773, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic potential of deformed phosphatidylserine-exposing microvesicles (D-PSVs) in managing inflammatory skin diseases by inhibiting M1 macrophage polarization and restoring immune balance.", "results_summary": "D-PSVs showed stronger and longer-lasting anti-inflammatory effects compared to conventional PSVs (C-PSVs) in macrophage models and reduced lesion severity in a psoriatic dermatitis mouse model, attributed to improved skin permeability and macrophage adhesion.", "population_specificity": "Primary bone marrow-derived macrophages and imiquimod-induced psoriatic dermatitis mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:52.706570+00:00"}
{"study_id": 31772, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether targeting externalized phosphatidylserine (PS) on cancer cells with a copper chelate could enhance immune responses and overcome resistance to PD-L1 blockade therapies.", "results_summary": "The study found that the copper chelate effectively capped externalized PS, promoting dendritic cell maturation, T-cell proliferation, and tumor infiltration while inhibiting PD-L1 expression. This led to tumor eradication in over 70% of mice with colorectal and melanoma cancers and induced robust immunological memory.", "population_specificity": "Mice with colorectal and melanoma cancers.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:52.771620+00:00"}
{"study_id": 31774, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the role of CD36 and phosphatidylserine in the fusion between monocytes (THP-1) and breast cancer cells (MCF-7), particularly under irradiation.", "results_summary": "The study found that irradiation increased phosphatidylserine expression in MCF-7 cells and enhanced THP-1/MCF-7 cell fusion, which was significantly reduced by inhibiting CD36-phosphatidylserine interaction.", "population_specificity": "In vitro study using THP-1 monocyte cell line and MCF-7 breast cancer cell line.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:53.887995+00:00"}
{"study_id": 31776, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Zn-D/DTH, a ROS-responsive polymeric prodrug targeting externalized phosphatidylserine (PS) on apoptotic cells, could mitigate ischemia-reperfusion-induced acute kidney injury (IR-AKI) by suppressing inflammation and apoptosis.", "results_summary": "Zn-D/DTH improved renal function, reduced pathological damage, and lowered pro-inflammatory factors (IL-6, COX-2, iNOS) by inhibiting the TLR4/MyD88/NF-\u03baB pathway and decreasing caspase activity, thereby delaying progression from acute to chronic kidney injury.", "population_specificity": "Preclinical study (likely animal model, not specified in abstract).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:55.214566+00:00"}
{"study_id": 31777, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the multifaceted roles of Phosphatidylserine (PS) in stroke pathophysiology and advocate for its potential as a novel therapeutic target.", "results_summary": "The study highlights PS as a promising candidate for stroke treatment due to its involvement in key post-stroke processes like apoptosis, inflammation, coagulation, and neuronal regeneration. It also discusses potential treatment strategies targeting PS.", "population_specificity": "Stroke patients (broadly discussed, not specific to a subgroup).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:55.275230+00:00"}
{"study_id": 31779, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the role of phosphatidylserine (PS) in activating thermogenesis in adipose tissue and its potential as a dietary intervention to counteract obesity.", "results_summary": "PS was found to promote thermogenesis, enhance mitochondrial function via the ADCY3-cAMP-PKA-PGC1\u03b1 pathway, and alleviate diet-induced obesity in mice. It also increased UCP1 expression and lipolysis in adipocytes.", "population_specificity": "Mice (in vivo) and adipocytes (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:56.459398+00:00"}
{"study_id": 31778, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of topical Phosphatidylserine (PS) on improving an imiquimod-induced psoriasis model in mice and compare its efficacy to cyclosporine A.", "results_summary": "Topical PS significantly reduced PASI scores, dermal thickness, erythema, and scaling in the psoriasis model. It also inhibited the gene expression of inflammatory cytokines (IL-17, IL-23, TNF-\u03b1) in the lesions.", "population_specificity": "Mice with imiquimod-induced psoriasis.", "effective_dosage": "Not specified.", "study_duration": "Five consecutive days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:56.734065+00:00"}
{"study_id": 31781, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether phosphatidylserine liposomes (PS-L) could enhance intracellular killing of Mycobacterium abscessus (Mab) in human macrophages and reduce proinflammatory responses, particularly in the context of cystic fibrosis (CF).", "results_summary": "PS-L improved intracellular killing of Mab by promoting phagosome acidification and ROS production, and it reduced proinflammatory responses (NF-kB activation and TNF-\u03b1 production) in infected macrophages, regardless of CFTR inhibition.", "population_specificity": "Human macrophages, including those with functional or pharmacologically inhibited CFTR (relevant to cystic fibrosis patients).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:01:57.079923+00:00"}
{"study_id": 31782, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential roles of Phosphatidylserine (PS) as a therapeutic target and Annexin A5 as a treatment in retinal vascular and degenerative diseases.", "results_summary": "The study suggests that PS is a novel lipid target linked to retinal diseases, acting upstream of VEGF and complement signaling, and Annexin A5 may inhibit PS signaling, offering a potential therapeutic approach beyond VEGF inhibition.", "population_specificity": "Patients with retinal vascular and degenerative diseases (e.g., retinal vein occlusion, diabetic retinopathy, wet age-related macular degeneration).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:01.086535+00:00"}
{"study_id": 31783, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the potential of a novel PS-targeting fusion protein (betabody) as an anti-tumor therapy, drug delivery vehicle, and imaging tool for the tumor microenvironment.", "results_summary": "The study found that betabodies bind to externalized PS with high affinity (~1 nM) without requiring a co-factor, localize robustly to the tumor microenvironment, and induce an immune stimulatory environment, demonstrating potential for therapeutic and diagnostic applications.", "population_specificity": "Tumor-associated endothelial cells, apoptotic tumor cells, and some viable tumor cells in the tumor microenvironment.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:01.220150+00:00"}
{"study_id": 31784, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential of Phosphatidylserine (PS) in improving survival rates and neurobehavioral outcomes in sepsis and sepsis-associated encephalopathy (SAE) in middle-aged mice.", "results_summary": "PS administration significantly increased survival rates, reduced neurobehavioral impairments, decreased neuronal apoptosis, and modulated proinflammatory cytokine expression in the hippocampus. It also preserved gut integrity and microbiome diversity in sepsis-survived mice.", "population_specificity": "Middle-aged mice with induced sepsis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Two months post-sepsis induction.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:02.509919+00:00"}
{"study_id": 31785, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify the molecular mechanisms, particularly the role of caspase-8 and phosphatidylserine (PS) exposure, in osteoclast fusion and bone resorption.", "results_summary": "The study found that RANKL-mediated activation of caspase-8 triggers PS exposure via Xkr8, facilitating osteoclast precursor fusion and bone resorption; blocking caspase-8 or PS exposure impaired fusion and increased bone mass in mice.", "population_specificity": "Mice with conditional deletion of caspase-8 in mononuclear osteoclast precursors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:03.574270+00:00"}
{"study_id": 31786, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the role of TMEM16F in neurodegeneration, specifically its involvement in tauopathy and microgliosis, and how it mediates aberrant phosphatidylserine exposure in neurons.", "results_summary": "The study found that TMEM16F deficiency reduced tauopathy and microgliosis in PS19 mice, particularly when removed from neurons, and that TMEM16F mediated aberrant phosphatidylserine exposure in neurons with phospho-tau burden.", "population_specificity": "PS19 mice (a mouse model expressing pathological P301S human tau).", "effective_dosage": "Not mentioned", "study_duration": "6 to 7 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:04.888212+00:00"}
{"study_id": 31788, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether phosphatidylserine-modified nanoparticles could enhance macrophage M2 polarization and suppress retinal neovascularization via cGAS-STING inhibition.", "results_summary": "The study found that phosphatidylserine-modified nanoparticles effectively promoted macrophage M2 polarization and reduced pathological angiogenesis in a murine oxygen-induced retinopathy model with a single intravitreal injection. The nanoparticles demonstrated biosafety and prolonged STING inhibition.", "population_specificity": "Murine (mouse) oxygen-induced retinopathy model.", "effective_dosage": "Single intravitreal injection (specific dosage not provided).", "study_duration": "Single administration (follow-up duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:05.158878+00:00"}
{"study_id": 31790, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the levels of Phosphatidylserine (PS) and TAM RTKs in plasma and on extracellular vesicles (EVs) in CLL patients compared to healthy volunteers to assess their potential as biomarkers or therapeutic targets.", "results_summary": "The study found a significant decrease in plasma PS levels in CLL patients compared to controls, but no significant change in PS levels on EVs. TAM RTKs on EVs showed a significant increase in CLL patients, suggesting potential as biomarkers or therapeutic targets.", "population_specificity": "25 CLL patients (Rai stage O-I, newly diagnosed or untreated) and 15 healthy volunteers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:06.432890+00:00"}
{"study_id": 31789, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to compare the therapeutic potential of different phosphatidylserine (PS)-modified liposomes in enhancing the uptake and anti-tumor effects of doxorubicin (DOX) liposomes.", "results_summary": "PS-modified liposomes (PS-CL-DOX) showed superior tumor growth inhibition and improved immune microenvironment modulation, though sialic acid-modified liposomes (SAL-DOX) exhibited the best overall anti-tumor effect. Liposomes prepared with DOPS as the PS material significantly enhanced uptake by RAW264.7 cells.", "population_specificity": "In vitro (S180 and RAW264.7 cells) and in vivo (mice) models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:06.703356+00:00"}
{"study_id": 31792, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore whether phosphatidylserine (PS) could serve as an inhibitory immune checkpoint in tumors and discuss strategies for targeting PS to reactivate the tumor-associated immune system.", "results_summary": "The study suggests that PS, when exposed on the extracellular leaflet of tumor cell membranes, may contribute to immune evasion by tumors. It highlights PS as a potential target for reactivating the immune system against cancer.", "population_specificity": "Tumor cells and their immune microenvironment (not human subjects).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:09.555506+00:00"}
{"study_id": 31791, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether RBC aggregation depends on the interaction between RBC membrane-bound phosphatidylserine (PS), extracellular calcium, and tissue factor.", "results_summary": "The study found that RBC aggregation was significantly higher with tissue factor (TF) and calcium combined, and this effect was reduced by Annexin V (a PS blocker), indicating PS plays a key role. RBCs treated with TF + calcium also showed faster thrombus formation in a pulmonary microcirculatory model.", "population_specificity": "Human whole blood and isolated RBCs in an in vitro setting.", "effective_dosage": "Not specified", "study_duration": "Not specified (in vitro experiments)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:10.551161+00:00"}
{"study_id": 31793, "supplement_id": 1441, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop a brain-targeted drug delivery system using Phosphatidylserine-based liposomes to overcome the blood-brain barrier for treating central nervous system diseases.", "results_summary": "The study found that phospholipase A2-catalyzed Phosphatidylserine liposomes efficiently delivered drugs into the brain with reversible BBB opening, demonstrating safety and simplicity in preparation.", "population_specificity": "Not specified (in vitro or animal model implied, but not explicitly stated).", "effective_dosage": "Effective dose mentioned, but exact amount not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:10.698352+00:00"}
{"study_id": 31794, "supplement_id": 1441, "safety_score": "70", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether targeting phosphatidylserine with bavituximab, combined with anti-PD-1 therapy (pembrolizumab), could enhance immunotherapy efficacy in unresectable hepatocellular carcinoma.", "results_summary": "The study found a confirmed response rate of 32.1% and median progression-free survival of 6.3 months, suggesting synergistic effects with PD-1 blockade without significantly increasing toxicity. Exploratory analyses linked tumor response to B-cell depletion, fibrotic tissue presence, and immune checkpoint expression in stroma.", "population_specificity": "Patients with unresectable hepatocellular carcinoma (28 evaluable participants).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:13.241161+00:00"}
{"study_id": 31796, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate whether PS-Omega3 (PUFA conjugated to a phospholipid vector) improves ADHD symptoms in children with epilepsy.", "results_summary": "The study found no significant difference in ADHD symptom reduction between PS-Omega3 and placebo groups at 12 or 24 weeks, suggesting no efficacy for this formulation in children with epilepsy and ADHD. The study was underpowered due to early termination.", "population_specificity": "Children aged 6-16 years with epilepsy and ADHD (inattentive or combined type).", "effective_dosage": "Not specified", "study_duration": "12-week double-blind treatment followed by a 12-week open-label period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:14.438721+00:00"}
{"study_id": 31797, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effectiveness of phosphatidylserine-functionalized liposome nanoparticles (Li NPs) in delivering genistein to the colon for targeted treatment of ulcerative colitis.", "results_summary": "The study found that phosphatidylserine-functionalized Li NPs effectively targeted macrophages and facilitated genistein internalization, while encapsulation in alginate microgels improved colonic retention and gradual release, significantly alleviating UC symptoms in mice.", "population_specificity": "Mice with dextran sulfate sodium salt (DSS)-induced ulcerative colitis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:14.985713+00:00"}
{"study_id": 31798, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of phosphatidylserine (PS) liposomes for targeted delivery of IL-10 to improve outcomes in intracerebral hemorrhage (ICH) by enhancing hematoma resolution and reducing neuroinflammation.", "results_summary": "PSL-IL10 treatment improved outcomes, accelerated hematoma resolution, inhibited glial activation, reduced pro-inflammatory cytokines, enhanced phagocytosis in microglia/macrophages, and activated STAT3/CD36 pathways.", "population_specificity": "Collagenase-induced ICH mouse model.", "effective_dosage": "3 \u03bcg IL-10 per mouse, intranasally administered 2 hours post-ICH.", "study_duration": "Acute phase post-ICH (specific duration not detailed).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:16.111823+00:00"}
{"study_id": 31799, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the connections between laboratory criteria and the prevalence of non-criteria antiphospholipid antibodies, including phosphatidylserine (aPS), in antiphospholipid syndrome (APS).", "results_summary": "The study found a significant association between aPS and criteria-antiphospholipid antibodies (aCL and a\u03b22GPI), but not with lupus anticoagulant (LA). aPS may be useful in assessing thrombotic risk, especially in patients negative for aCL/a\u03b22GPI or with isolated LA positivity.", "population_specificity": "300 patients with thrombosis.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:18.505321+00:00"}
{"study_id": 31801, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether DHA-PS and EPA-PS could directly protect primary hippocampal neurons against oxidative damage and explore their neuroprotective mechanisms.", "results_summary": "DHA-PS and EPA-PS improved cell morphology, restored neural networks, alleviated oxidative stress-mediated mitochondrial dysfunction, and reduced p-GSK3\u03b2 and p-Tau expression. EPA-PS also inhibited ERK phosphorylation, increased p-TrkB and p-CREB expression, and enhanced synaptic plasticity.", "population_specificity": "Primary hippocampal neurons (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:19.403988+00:00"}
{"study_id": 31802, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of mitochondrial phosphatidylserine (PS) in uric acid-induced mitochondrial dysfunction and apoptosis.", "results_summary": "High uric acid levels increased mitochondrial PS and decreased phosphatidylethanolamine (PE), while downregulating PISD, leading to mitochondrial dysfunction and apoptosis. Interventions like PISD overexpression and lyso-PE administration mitigated these effects.", "population_specificity": "Individuals with hyperuricemia and mouse/human liver cell models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:21.864618+00:00"}
{"study_id": 31803, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether recombinant human annexin A5 (Anx5) inhibits endothelial inflammation induced by activated platelets and microvesicles in septic conditions via phosphatidylserine binding.", "results_summary": "Wildtype Anx5 reduced inflammatory cytokine expression and adhesion molecules in endothelial cells under septic conditions, improved trans-endothelial electrical resistance, and decreased monocyte and platelet adhesion, while Anx5 mutant deficient in phosphatidylserine binding did not show these effects.", "population_specificity": "Rodent sepsis models and vascular endothelial cells in vitro.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:22.827287+00:00"}
{"study_id": 31800, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether peptoids, which mimic antimicrobial peptides, could disrupt viral membranes by preferentially interacting with phosphatidylserine (PS).", "results_summary": "The study found that peptoids selectively disrupted liposomes containing phosphatidylserine (PS) but not those with phosphatidylcholine (PC), and chikungunya virus with elevated envelope PS was more susceptible to peptoid-mediated inactivation. These results suggest PS engagement as a potential antiviral mechanism.", "population_specificity": "In vitro study using liposomes and enveloped viruses (Zika, Rift Valley fever, chikungunya).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:23.242907+00:00"}
{"study_id": 31804, "supplement_id": 1441, "safety_score": "85", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to investigate the efficacy of a dietary supplement containing Phosphatidylserine, among other ingredients, in improving symptoms and pain in patients with mild to moderate Carpal Tunnel Syndrome (CTS).", "results_summary": "The study found that the supplement significantly improved symptoms and pain (measured by BCTQ) but did not significantly improve functional outcomes. A small percentage (14.5%) of patients in the treatment group reported no need for further treatment, and no major side effects were noted.", "population_specificity": "Outpatients with mild to moderate CTS awaiting surgical decompression.", "effective_dosage": "600 mg twice daily (as part of a blend with other ingredients).", "study_duration": "60 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:24.132936+00:00"}
{"study_id": 31805, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effectiveness and mechanism of a combination therapy involving a TLR9 activator (CpG-2722) and a phosphatidylserine (PS)-targeting prodrug (BPRDP056) in a head and neck cancer animal model.", "results_summary": "The study found that CpG-2722 and BPRDP056 had a cooperative antitumor effect, with CpG-2722 enhancing immune responses and BPRDP056 directly killing cancer cells. TLR9 activation increased PS exposure on cancer cells, improving BPRDP056 targeting and creating a positive feedback loop for tumor killing.", "population_specificity": "Syngeneic orthotopic head and neck cancer animal model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:25.725559+00:00"}
{"study_id": 31806, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the role of anti-phosphatidylserine (PS) autoantibodies produced by B1a cells in the development of lupus nephritis (LN) in systemic lupus erythematosus (SLE).", "results_summary": "Elevated PS-specific IgG levels were found in lupus model mice and SLE patients, particularly those with LN. PS-specific B1a cells were identified as the primary source of these autoantibodies, and their depletion attenuated lupus progression, while TLR/Syk signaling blockade inhibited PS-specific IgG secretion.", "population_specificity": "Lupus model mice and SLE patients, especially those with lupus nephritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:27.305501+00:00"}
{"study_id": 31807, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether engineered T cells with a chimeric engulfment receptor (CER-1236) targeting phosphatidylserine could enhance phagocytic clearance and anti-tumor immune responses.", "results_summary": "CER-1236 T cells demonstrated target-dependent phagocytic function, enhanced cytotoxic effects, and superior cross-presentation ability, leading to improved anti-tumor responses in pre-clinical models of mantle cell lymphoma and EGFR-positive non-small cell lung cancer.", "population_specificity": "Pre-clinical models (in vitro and in vivo) of mantle cell lymphoma (MCL) and EGFR mutation-positive non-small cell lung cancer (NSCLC).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:28.514086+00:00"}
{"study_id": 31795, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To examine the effect of topical phosphatidylserine (PS) on wound healing factors and tissue necrosis in rat models.", "results_summary": "Topical PS significantly enhanced fibroblast and endothelium numbers, reduced neutrophils and macrophages, improved collagen deposition, epithelialization, and wound recovery (near 80%). It also elevated FGF and VEGF levels and reduced necrotic areas, outperforming control treatments (PHT and CsA).", "population_specificity": "Rat models with induced wounds and skin flap necrosis.", "effective_dosage": "Not specified", "study_duration": "14 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:30.494824+00:00"}
{"study_id": 31810, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the role of phosphatidylserine (PS) in tumor progression, metastasis, and coagulation activation, as well as potential therapeutic interventions targeting PS.", "results_summary": "The study found that PS externalization on microparticles contributes to coagulation activation and tumor dissemination processes, including immune escape and angiogenesis. Lactadherin and coagulation factor inhibitors showed potential in delaying tumor progression by competing for PS binding sites.", "population_specificity": "Not specified (review of existing evidence, not a clinical trial).", "effective_dosage": "Not available", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:31.314856+00:00"}
{"study_id": 31808, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to identify methods for solubilizing and purifying the native form of Cho1 (Phosphatidylserine synthase) from Candida albicans to facilitate drug discovery for antifungal treatments.", "results_summary": "The study successfully solubilized and purified Cho1 as a hexamer, optimized its enzyme activity, and identified digitonin or DDM as the most effective detergents for maintaining PS synthase activity. The purified Cho1 exhibited cooperative binding for serine and a Km of 72.20 \u03bcM for CDP-diacylglycerol.", "population_specificity": "Candida albicans (fungal pathogen)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:32.066208+00:00"}
{"study_id": 31809, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to characterize apoptotic vesicles (apoVs) derived from mesenchymal stem cells (MSCs) and explore their immunomodulatory potential, particularly focusing on the role of phosphatidylserine (PtdSer/PS) in mediating interactions with T cells.", "results_summary": "The study found that apoVs, through exposed phosphatidylserine, interacted with CD4+ T cells, suppressed CD25 expression and IL-2 production, and inhibited Th1/2/17 subsets and cytokines while maintaining Foxp3+ cells. ApoVs also prevented Th17 differentiation, ameliorated inflammation, and improved joint erosion in murine arthritis.", "population_specificity": "Fas mutant mice and murine arthritis models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:32.478690+00:00"}
{"study_id": 31811, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of a novel electric field modality on cancer biomarkers, particularly cell surface phosphatidylserine (PS), in normal and cancer cell lines.", "results_summary": "The study found that the electric field modality successfully modulated cell surface phosphatidylserine (PS) in cancer cell lines. Moderate amplitude EF induced p38 MAPK activation, actin polymerization, and cell cycle arrest in cancer cells, suggesting a potential mechanism for EF-mediated PS exposure.", "population_specificity": "In vitro study using normal human astrocytes, human pancreatic ductal epithelial (HDPE) cells, and cancer cell lines (glioblastoma U87-GBM, human pancreatic cancer cfPac-1, and MiaPaCa-2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:33.319560+00:00"}
{"study_id": 31812, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge of phosphatidylethanolamine metabolism to identify future research areas for potential treatments.", "results_summary": "The study highlights genetic disorders impacting phosphatidylethanolamine pathways, emphasizing the importance of phospholipid homeostasis for neuronal function. It does not directly assess Phosphatidylserine's effects but focuses on metabolic pathways.", "population_specificity": "Individuals with genetic disorders affecting phosphatidylethanolamine metabolism (e.g., hereditary spastic paraplegia, Liberfarb syndrome, CONATOC).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:33.736069+00:00"}
{"study_id": 31813, "supplement_id": 1441, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to explore the tolerogenic properties of Phosphatidylserine (PS) and its potential for inducing oral tolerance to prevent/reduce immune responses against various antigens.", "results_summary": "The study found that PS exposure on cells or vesicles promotes a tolerogenic environment by engaging receptors like TIM-4, effectively converting immunogens into tolerogens. This approach showed promise in preventing immune responses against protein-based therapies, food allergens, autoantigens, and viral capsid peptides.", "population_specificity": "Not specified (broad potential clinical applications implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:36.739240+00:00"}
{"study_id": 31814, "supplement_id": 1441, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether distearoyl-phosphatidylserine (DSPS)-containing nanoparticles could effectively deliver c-Rel siRNA to immune cells and inhibit c-Rel expression.", "results_summary": "DSPS-LNP improved uptake by immune cells, effectively transfected macrophages, neutrophils, and lymphocytes, and significantly inhibited c-Rel expression in phagocytes for several days. Higher DSPS concentrations broadened transfection efficacy across immune cell types with limited toxicity.", "population_specificity": "Immune cells (macrophages, neutrophils, lymphocytes) in vitro.", "effective_dosage": "High and low concentrations of DSPS in LNP (specific amounts not detailed).", "study_duration": "Effects lasted several days (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:38.476163+00:00"}
{"study_id": 31816, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the characteristics of Phosphatidylserine, including its synthesis, translocation, functions, and detection methods, to understand its role in the nervous system.", "results_summary": "The study highlights Phosphatidylserine's involvement in neurodevelopmental processes and neurodegenerative diseases, particularly its role in regulating signaling pathways and microglia-mediated synaptic and neuronal phagocytosis. It also reviews detection materials to further explore its functions in the nervous system.", "population_specificity": "Not specified (general review of Phosphatidylserine in eukaryotic cells and nervous system contexts)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:40.378316+00:00"}
{"study_id": 31815, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the regulatory roles of Phosphatidylserine (PS) in diabetes and explore its potential for diabetic therapy, including insulin sensitivity and complications.", "results_summary": "The study found that PS participates in controlling insulin secretion, regulating insulin signaling, and mitigating diabetic complications by targeting mitochondria and coagulation disorders. PS supplements and PS-containing liposomes showed protective effects against type 1 and type 2 diabetes in animal studies.", "population_specificity": "Animal models (type 1 and type 2 diabetes).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:40.498499+00:00"}
{"study_id": 31817, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the association between anti-phosphatidylserine (aPS) antibodies and cardiovascular risk, organ involvement, and disease activity in systemic lupus erythematosus (SLE) patients.", "results_summary": "Higher levels of aPS were significantly associated with Raynaud's phenomenon, while aPE (a related antibody) was linked to renal involvement, cerebral stroke, and disease activity markers. The study suggests aPS and aPE may indicate vascular and thrombotic risks in SLE patients.", "population_specificity": "93 SLE patients and 30 controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:40.699336+00:00"}
{"study_id": 31819, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the mechanisms of phosphatidylserine (PS)-mediated phagocytosis, focusing on receptors, signaling cascades, and phagocytic cup formation.", "results_summary": "The abstract highlights that PS-mediated phagocytosis is crucial for apoptotic cell removal but remains poorly understood due to receptor redundancy and complex signaling networks. It summarizes recent progress in understanding PS recognition and phagocytosis coordination.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not mentioned", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:40.807347+00:00"}
{"study_id": 31818, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether soybean-derived phosphatidylserine (PS) could inhibit squamous cell carcinoma (SCC) initiation and enhance chemotherapy sensitivity in tongue and esophageal cancers.", "results_summary": "The study found that PS administration inhibited SCC initiation in cells with low OTUB2 expression and increased their sensitivity to chemotherapy, suggesting a tumor-suppressive role for the OTUB2/STAT1/CALML3/PS axis.", "population_specificity": "Mouse models of tongue and esophageal squamous cell carcinomas.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:40.902411+00:00"}
{"study_id": 31820, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the efficacy of a small molecule-based immune checkpoint-targeting maytansinoid conjugate (including conjugate 40a) in treating pancreatic cancer, triple-negative breast cancer, and sorafenib-resistant liver cancer.", "results_summary": "Conjugate 40a induced lasting tumor regression and transformed the immunosuppressive tumor microenvironment into an \"inflamed hot tumor\" with elevated gene expressions not seen in vehicle-treated tumors. The study suggests this approach could be combined with existing immune-oncology treatments.", "population_specificity": "Models of pancreatic cancer, triple-negative breast cancer, and sorafenib-resistant liver cancer (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:42.876703+00:00"}
{"study_id": 31821, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether phosphatidylserine (PS) liposomes could function as antigen delivery vesicles to mimic apoptotic cells and potentially treat autoimmune diseases.", "results_summary": "The study found that PS liposomes accumulated in the spleen's marginal zone due to recognition by marginal zone macrophages (MZMs), suggesting their potential as therapeutic agents for autoimmune diseases. Liposomes without PS did not show this accumulation, indicating PS's crucial role in targeting MZMs.", "population_specificity": "Not specified (likely preclinical, involving macrophages and/or animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:45.601284+00:00"}
{"study_id": 31822, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether DHA-enriched phosphatidylserine (DHA-PS) could mitigate high-fat diet-induced kidney injury in mice.", "results_summary": "DHA-PS treatment reduced body weight, improved kidney function markers (e.g., serum urea nitrogen, creatinine), decreased lipid accumulation and inflammation, and modulated oxidative stress and metabolic pathways. It also influenced intestinal microbiota, suggesting a potential dietary supplement role for kidney injury alleviation.", "population_specificity": "Mice fed a high-fat diet.", "effective_dosage": "20 and 40 mg/kg DHA-PS.", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:46.811290+00:00"}
{"study_id": 31825, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine how gain-of-function and dominant-negative mutations in TRPC6 affect platelet activation, including phosphatidylserine exposure, in murine models.", "results_summary": "The study found that gain-of-function TRPC6 mutations enhanced calcium influx, integrin activation, P-selectin exposure, and phosphatidylserine exposure in platelets, while dominant-negative mutations abolished these effects. TRPC6 activity was shown to modulate platelet activation pathways beyond its typical role, indicating a true gain-of-function phenotype.", "population_specificity": "Murine (mouse) platelets", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:49.671171+00:00"}
{"study_id": 31824, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of a dietary supplement containing phosphatidylserine and docosahexaenoic acid on cognitive performance in a D-galactose-induced aging rat model.", "results_summary": "The dietary supplement improved cognitive performance, increased antioxidant activity, reduced oxidative stress and inflammation, inhibited astrocyte activation, and elevated neurotrophic factors in aged rats. These effects suggest potential benefits for cognitive restoration in aging populations.", "population_specificity": "Seven-month-old male Sprague-Dawley rats with D-galactose-induced aging.", "effective_dosage": "Low-dose (2 g/kg), medium-dose (6 g/kg), and high-dose (10 g/kg) body weight.", "study_duration": "13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:49.807625+00:00"}
{"study_id": 31823, "supplement_id": 1441, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the levels of phosphatidylserine-exposed red blood cells (PS-exposed RBCs) and ineffective erythropoiesis biomarkers in patients with different thalassemia genotypes.", "results_summary": "PS-exposed RBC levels were significantly higher in splenectomized beta-thalassemia patients, and beta-thalassemia patients had the highest GDF-15 levels. Splenectomy improved hemoglobin levels and reduced GDF-15 in non-deletional alpha-thalassemia patients but not in beta-thalassemia patients.", "population_specificity": "139 patients aged 18 years and above with different thalassemia genotypes at Srinagarind Hospital, Khon Kaen University, Thailand.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:50.296750+00:00"}
{"study_id": 195975, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of preoperative probiotic administration in children undergoing surgery, particularly focusing on bacteremia.", "results_summary": "The study discusses the relationship between probiotics and their perioperative effects, but the clinical significance in children remains unclear. The abstract mentions a randomized controlled trial but does not provide specific outcome data.", "population_specificity": "Children undergoing surgery", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:57.142792+00:00"}
{"study_id": 195973, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotic supplementation on body weight, BMI, fat mass, and fat percentage in overweight individuals.", "results_summary": "The study conducted a systematic review and meta-analysis of randomized controlled trials, but the abstract does not specify the exact outcomes regarding the effectiveness of probiotics on weight-related metrics.", "population_specificity": "Subjects with overweight (BMI 25-29.9 kg/m\u00b2).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:57.463552+00:00"}
{"study_id": 195972, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of dietary and physical activity programs, including probiotics, on blood glucose and lipid profiles in patients with type 2 diabetes aged 60 and over.", "results_summary": "The study found that probiotics, along with other dietary and physical activity interventions, improved blood glucose levels and lipid profiles in patients with type 2 diabetes.", "population_specificity": "Patients with type 2 diabetes aged 60 years and over.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:57.874995+00:00"}
{"study_id": 195974, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotic supplementation reduces the risk of retinopathy of prematurity (ROP) in preterm infants by preventing infections.", "results_summary": "Probiotics significantly reduced the risk of late-onset sepsis (LOS) but did not show a significant effect on the risk of any stage ROP or severe ROP. Meta-regression found no association between the reduction in LOS and severe ROP risk.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:58.404907+00:00"}
{"study_id": 195968, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review recent findings on the role of gut microbiota and probiotics in immune tolerance, bacteremia, gut dysbiosis, and systemic inflammation.", "results_summary": "The abstract highlights that butyrate-metabolizing commensal microbiota induces colonic Treg cell differentiation, synbiotic supplementation ameliorates bacteremia in surgical patients, and gut dysbiosis is linked to altered metabolism and inflammation in ischemic stroke patients.", "population_specificity": "Surgical patients, pediatric surgical cases, type 2 diabetes patients, C-section-born infants, and ischemic stroke patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:58.703902+00:00"}
{"study_id": 195970, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of probiotics and synbiotics on serum concentrations of liver function enzymes in adults.", "results_summary": "Probiotics and synbiotics significantly reduced serum levels of alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyl transpeptidase, with more pronounced improvements in individuals with liver disease and when administered for \u22658 weeks. No significant changes were observed in alkaline phosphatase or albumin, while bilirubin levels favored the control group.", "population_specificity": "Adults, particularly those with liver disease.", "effective_dosage": "Not specified", "study_duration": "Varied, with \u22658 weeks showing more pronounced effects.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:58.898962+00:00"}
{"study_id": 195971, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether probiotic supplementation reduces the risk of bronchopulmonary dysplasia (BPD) in preterm infants.", "results_summary": "The meta-analysis found a significant reduction in necrotizing enterocolitis (NEC) risk with probiotic use (RR 0.52, 95% CI 0.33 to 0.81), but BPD was not assessed as a primary outcome in any included study.", "population_specificity": "Preterm infants (4782 total, 2406 receiving probiotics).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:58.946289+00:00"}
{"study_id": 195969, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 20, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of Lactobacillus rhamnosus GG (LGG) on clinical outcomes, including respiratory and nutritional measures, in children with cystic fibrosis (CF).", "results_summary": "The study found that LGG supplementation did not significantly reduce pulmonary exacerbations, hospitalizations, or improve body mass index and FEV1 in children with CF. No significant benefits were observed under the trial conditions.", "population_specificity": "Children with cystic fibrosis (CF), aged 2 to 16 years.", "effective_dosage": "6\u00d710^9 CFU (frequency not specified).", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:02:58.947613+00:00"}
{"study_id": 195980, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of probiotic supplementation in improving bone density and protecting against primary and secondary osteoporosis.", "results_summary": "The study highlights that probiotics can increase bone density in healthy individuals and protect against osteoporosis, particularly in cases of estrogen deficiency and secondary disease pathology, based on murine studies.", "population_specificity": "Murine (animal) models, with implications for human bone health.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:06.148042+00:00"}
{"study_id": 195979, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To determine if yogurt supplemented with a probiotic strain (N1115) could reduce the risk of acute upper respiratory tract infections (URTI) in middle-aged and elderly individuals.", "results_summary": "The intervention group showed a significant decrease in both the number of individuals diagnosed with acute URTI and the number of URTI events compared to the control group, suggesting probiotic-enhanced yogurt may lower infection risk. The study proposed enhanced T-cell-mediated immune defense as a potential mechanism.", "population_specificity": "Middle-aged and elderly volunteers aged \u226545 years.", "effective_dosage": "300 mL/d of probiotic-supplemented yogurt.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:06.625930+00:00"}
{"study_id": 195976, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study did not aim to evaluate probiotics, as it excluded studies on supplementation such as probiotics.", "results_summary": "The study did not examine probiotics, as it focused on dietary modifications and excluded supplementation studies.", "population_specificity": "Not applicable (probiotics not studied)", "effective_dosage": "Not applicable", "study_duration": "Not applicable", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:07.032004+00:00"}
{"study_id": 195982, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy and safety of probiotics in reducing the need for phototherapy and its duration in neonatal hyperbilirubinemia.", "results_summary": "Probiotic supplementation reduced the duration of phototherapy and total serum bilirubin levels at 96 hours and 7 days, but did not significantly reduce the incidence of jaundice. No probiotic-related adverse effects were reported.", "population_specificity": "Neonates (any gestation or weight) with hyperbilirubinemia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:07.630247+00:00"}
{"study_id": 195984, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a probiotic mixture (Saccharomyces boulardii and Enterococcus faecium) on tear film parameters and microbiological activity in subjects with Dry Eye Syndrome (DES).", "results_summary": "The probiotic group showed significant improvements in Schirmer I and II tests, tear breakup time (BUT), and a reduction in bacterial growth compared to the control group. The probiotic also reduced the number of aerobic and anaerobic bacterial isolates.", "population_specificity": "60 subjects with Dry Eye Syndrome (30 in the control group, 30 in the probiotic group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:08.337726+00:00"}
{"study_id": 195981, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to analyze the effects of high-concentration multistrain probiotic supplementation on neurocognitive abilities and evaluate its safety in cART-treated HIV-1-positive patients with long-term virologic suppression.", "results_summary": "The study found significant improvements in several neurocognitive tests (RAVLT, ROCF, PVF, Tas-20, STAY Y-2, STEP) and confirmed the safety of probiotic supplementation without altering miRNA-29 levels in CSF.", "population_specificity": "cART-treated HIV-1-positive patients with long-term virologic suppression.", "effective_dosage": "High-concentration multistrain probiotic (Vivomixx\u00ae; Visbiome\u00ae), exact dosage not specified.", "study_duration": "6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:08.981648+00:00"}
{"study_id": 195985, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Bifidobacterium animalis subsp. lactis BB-12 on cholesterol levels and fecal short-chain fatty acids (SCFAs) in adults.", "results_summary": "The study found no significant differences in total cholesterol, LDL-C, HDL-C, or triglycerides after probiotic treatment. Fecal acetate increased significantly after yogurt smoothie and prebiotic periods, but no changes were observed in other SCFAs. Fecal total SCFAs were negatively associated with TC, LDL-C, age, and waist circumference.", "population_specificity": "30 adults (11 men, 19 women) aged 18-40 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:09.254833+00:00"}
{"study_id": 195977, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 45, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotics and zinc supplementation could improve the immunogenicity of oral rotavirus vaccine in infants.", "results_summary": "Probiotics showed a modest but non-significant improvement in seroconversion rates (7.5% difference, p=0.066), while zinc had no significant effect. No serious adverse events were related to the interventions.", "population_specificity": "Infants 5 weeks old living in urban Vellore, India.", "effective_dosage": "Probiotic (10^10 CFU/day) and zinc (5mg/day).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:10.187920+00:00"}
{"study_id": 195987, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplemental probiotics improve glucose and lipid metabolism and reduce C-reactive protein (CRP) levels in type 2 diabetic patients.", "results_summary": "Probiotics significantly reduced HbA1c, fasting insulin, and HOMA-IR levels, but effects on FPG, CRP, and lipid profile were either non-significant or highly heterogeneous.", "population_specificity": "Type 2 diabetic patients (684 participants across 12 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:13.880630+00:00"}
{"study_id": 195988, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between gut microbiota (including probiotics) and bone health, examining effects on bone remodeling, development, and mechanical strength.", "results_summary": "The study found that manipulation of gut microbiota (via probiotics, antibiotics, or germ-free models) significantly impacts bone remodeling, development, and strength, though effects were context-dependent. Discrepancies in findings suggest complex interactions between microbiota and bone.", "population_specificity": "Germ-free mice and antibiotic-treated models (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:14.944653+00:00"}
{"study_id": 195989, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of a probiotic mixture (Bifidobacterium lactis and Bifidobacterium bifido) on tear film and bacterial growth in patients with Dry Eye Syndrome (DES).", "results_summary": "The probiotic group showed significant improvements in Schirmer test scores and tear film stability (BUT) compared to the control group. Bacterial growth was reduced in the probiotic group, indicating a potential systemic immune benefit.", "population_specificity": "40 subjects with Dry Eye Syndrome (20 in control group, 20 in probiotic group).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:15.822180+00:00"}
{"study_id": 195990, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of probiotic supplementation in preventing radiation-induced diarrhea in patients undergoing abdominal or pelvic radiotherapy.", "results_summary": "Probiotics were associated with a lower incidence of radiation-induced diarrhea compared to placebo, but no significant difference was found in anti-diarrheal medication use or stool form. The results showed high heterogeneity among studies.", "population_specificity": "Patients receiving radiotherapy for abdominal or pelvic cancers.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:16.600033+00:00"}
{"study_id": 195992, "supplement_id": 1474, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of probiotic supplementation (Saccharomyces boulardii) on gut and throat microbiota alterations and antibiotic resistance following anti-Helicobacter pylori concomitant therapy.", "results_summary": "Probiotic supplementation stabilized throat microbiota changes more effectively than no supplementation, but did not significantly restore unbalanced gut and throat microbiota. Higher antibiotic resistance rates were observed post-treatment.", "population_specificity": "Patients undergoing anti-Helicobacter pylori concomitant therapy.", "effective_dosage": "Not specified", "study_duration": "Follow-up until Day 71", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:17.205877+00:00"}
{"study_id": 195991, "supplement_id": 1474, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to review the effects of probiotics and synbiotics on intestinal chronic diseases, focusing on immune modulation and anti-inflammatory responses in in vitro, animal, and human studies.", "results_summary": "Probiotics demonstrated anti-inflammatory properties in vitro and improved clinical symptoms and histological alterations in animal studies, though caution was advised during IBD relapse stages. Probiotic supplementation was found to be well tolerated and effective in IBD patients, including those with CD and UC.", "population_specificity": "Patients with intestinal chronic diseases, particularly IBD (Crohn's disease and ulcerative colitis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:17.669350+00:00"}
{"study_id": 195994, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether short-term probiotic supplementation affects resting cardiovascular measures and cardiovascular/psychological responses to acute psychological stress in healthy young adults.", "results_summary": "The study found no significant effects of 2-week probiotic supplementation on resting cardiovascular function, stress-induced cardiovascular responses, or psychological reactions to stress compared to placebo.", "population_specificity": "Healthy young adults (N = 105, mean age 20.17, 84.8% white) without prior probiotic use, gastrointestinal disorders, or current antibiotic use.", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:18.285604+00:00"}
{"study_id": 195995, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effect of probiotics on fasting plasma glucose, insulin resistance, and LDL-cholesterol levels in pregnant women diagnosed with gestational diabetes mellitus (GDM).", "results_summary": "Probiotic supplementation was not effective in decreasing fasting blood glucose levels, with a mean difference of -0.13 (95% CI -0.32, 0.06). The study included four high-quality RCTs but found no significant metabolic benefits from probiotics in this population.", "population_specificity": "Pregnant women diagnosed with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "6-8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:19.191659+00:00"}
{"study_id": 195996, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of a high-concentration multistrain probiotic on intestinal immunity in ART-experienced HIV-1 patients.", "results_summary": "The study found a reduction in CD4+ T-cell activation and improved mucosal integrity, suggesting potential benefits for gut barrier immunity in HIV-1 patients.", "population_specificity": "ART-experienced HIV-1-positive patients", "effective_dosage": "Twice daily", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:21.056503+00:00"}
{"study_id": 195997, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effectiveness of probiotic supplementation in preventing necrotising enterocolitis (NEC) and death in very low-birth-weight (VLBW) infants and to investigate differences in efficacy by probiotic agent.", "results_summary": "Probiotics significantly reduced NEC incidence and mortality in VLBW infants, though outcomes varied based on probiotic agent, prenatal steroids, and feeding regimens.", "population_specificity": "Very low-birth-weight (VLBW) infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:23.076910+00:00"}
{"study_id": 196000, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 60, "study_goal": "The researchers aimed to systematically review the role of probiotics in improving gut microbiota and clinical outcomes in neonates with major gastrointestinal surgical conditions.", "results_summary": "The study found limited and mixed evidence on probiotics' effects, with one trial showing higher Bifidobacteriaceae and lower Clostridiaceae in the probiotic group, while another reported more Streptococcaceae in the probiotic group and more Bifidobacteriaceae in the control group.", "population_specificity": "Neonates with major gastrointestinal surgical conditions (e.g., gastroschisis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:25.302095+00:00"}
{"study_id": 195998, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy and safety of probiotic supplementation for managing cystic fibrosis, particularly its impact on pulmonary exacerbation and intestinal inflammation.", "results_summary": "The included studies supported the use of probiotics for managing pulmonary exacerbation and reducing intestinal calprotectin in cystic fibrosis patients, but the evidence was limited due to a lack of high-quality RCTs.", "population_specificity": "Pediatric and adult patients with cystic fibrosis (188 participants across five studies).", "effective_dosage": "Not specified", "study_duration": "1 month to 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:25.318026+00:00"}
{"study_id": 196001, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether an oral probiotic preparation is superior to placebo in improving digestive and immune function in healthy, formula-fed infants.", "results_summary": "The study design suggests potential benefits of probiotics in altering fecal microbiota (particularly Bifidobacterium bifidum) and immune markers (salivary SIgA), but results are pending as the abstract describes a planned trial rather than completed findings.", "population_specificity": "Exclusively formula-fed healthy infants aged 4 to 6 months in Shanghai, China.", "effective_dosage": "Once daily for 4 weeks (specific CFU not stated).", "study_duration": "4-week intervention with 8-week follow-up (14 weeks total).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:26.483733+00:00"}
{"study_id": 196002, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether supplementation with the probiotic Lactobacillus rhamnosus HN001 could reduce the prevalence of gestational diabetes mellitus (GDM) in pregnant women.", "results_summary": "The study found a trend toward lower GDM rates with HN001, particularly in women aged \u226535 years and those with a history of GDM. Using the NZ definition, GDM prevalence was significantly lower in the HN001 group compared to placebo.", "population_specificity": "Pregnant women (14-16 weeks' gestation) with a personal or partner history of atopic disease in New Zealand.", "effective_dosage": "6\u00d710^9 colony-forming units daily", "study_duration": "From 14-16 weeks' gestation until 24-30 weeks' gestation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:27.305187+00:00"}
{"study_id": 196004, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of Bifidobacterium animalis subspecies lactis Bl-04 on innate and adaptive immune responses to experimental rhinovirus challenge, specifically focusing on CXCL8 response.", "results_summary": "Probiotic supplementation reduced CXCL8 response to rhinovirus infection, lowered nasal lavage virus titre, and decreased virus shedding, but did not affect lower respiratory inflammation, symptom scores, or infection rate.", "population_specificity": "152 seronegative volunteers (73 probiotic, 79 placebo) challenged with RV-A39.", "effective_dosage": "Not specified in the abstract.", "study_duration": "28 days of supplementation followed by 5 days post-challenge.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:27.714071+00:00"}
{"study_id": 196005, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotics on blood pressure and lipid profile in type 2 diabetic patients.", "results_summary": "Probiotic consumption significantly reduced systolic and diastolic blood pressure, total cholesterol, LDL-C, and triglycerides in type 2 diabetic patients compared to placebo. The study concluded that probiotics may help control dyslipidemia and hypertension in this population.", "population_specificity": "Type 2 diabetic patients (n = 641 across 11 randomized controlled trials).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:27.788917+00:00"}
{"study_id": 196006, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of probiotics on blood pressure in hypertensive animal models and human patients, focusing on microbiota changes.", "results_summary": "Probiotic supplementation was found to reduce blood pressure in human studies, though the exact mechanisms (e.g., gut microbiota changes, barrier function restoration) remain unclear. Gut dysbiosis in hypertension involves reduced diversity, altered bacterial ratios, and shifts in metabolite-producing populations.", "population_specificity": "Hypertensive animal models and human patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:29.180376+00:00"}
{"study_id": 196007, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of probiotics in preventing or treating small intestinal bacterial overgrowth (SIBO) through a meta-analysis and systematic review.", "results_summary": "Probiotics showed a significantly higher SIBO decontamination rate, reduced H2 concentration, and relieved abdominal pain, but were ineffective in preventing SIBO and did not significantly reduce daily stool frequency.", "population_specificity": "Patients with or at risk of small intestinal bacterial overgrowth (SIBO).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:32.647594+00:00"}
{"study_id": 196008, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "To develop and validate a method for isolating Bifidobacterium animalis ssp. lactis BB-12 (BB-12) from fecal samples and apply it to study the recovery of BB-12 and Lactobacillus rhamnosus GG (LGG) from the GI tract of healthy humans.", "results_summary": "The study successfully developed a novel method for isolating BB-12 with high accuracy (97-104% recovery) and demonstrated the recovery of viable BB-12 and LGG from the GI tract of healthy humans consuming a probiotic supplement.", "population_specificity": "Healthy humans", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:34.842784+00:00"}
{"study_id": 196010, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effects of probiotics on glycemic control and lipid metabolism in patients with type 2 diabetes mellitus (T2DM).", "results_summary": "Probiotics significantly reduced fasting blood glucose by -11.27mg/dL and serum insulin concentration by -2.36\u03bcU/mL, but did not significantly reduce HbA1c. The study concluded that probiotics can improve glucose control and lipid metabolism in T2DM patients.", "population_specificity": "Patients with type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:34.913593+00:00"}
{"study_id": 196011, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to explore the potential mechanisms by which probiotics may prevent colorectal cancer and assess their anticarcinogenic effects.", "results_summary": "The study suggests that probiotics can modulate intestinal microbiota, degrade carcinogens, produce anticarcinogenic compounds, and induce apoptosis in cancer cells, potentially preventing colorectal cancer. Few adverse effects were reported.", "population_specificity": "Not specified (general discussion of mechanisms, no specific population studied).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:35.264502+00:00"}
{"study_id": 196012, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the direct and indirect health benefits of probiotics, focusing on their mechanisms of action against pathogens and their role in promoting overall health.", "results_summary": "Probiotics demonstrate significant health benefits, including prevention of diarrhea, atopic eczema, and colorectal cancers, as well as treatment of inflammatory bowel disease. They exert direct effects on pathogens through antimicrobial production, competitive exclusion, and immune enhancement.", "population_specificity": "General human population (not specified further).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:35.586045+00:00"}
{"study_id": 196014, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to explore the relationship between gut microbiota and migraine headaches, including the potential effects of probiotics on migraine frequency and severity.", "results_summary": "The review suggests a potential link between gut microbiota and migraine headaches, with probiotics possibly benefiting migraine frequency and severity, but clinical evidence is limited and large-scale trials are needed.", "population_specificity": "Patients with migraine headaches and gastrointestinal disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:38.375535+00:00"}
{"study_id": 196013, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether multiple-strain probiotics are more effective than single-strain probiotics in reducing necrotizing enterocolitis (NEC) and mortality in preterm very low birth weight (PVLBW) infants.", "results_summary": "The meta-analysis found that multiple-strain probiotics significantly reduced the incidence of NEC (OR 0.36) and mortality (OR 0.58), while single-strain probiotics (Lactobacillus species) showed only a borderline effect on NEC and no effect on mortality. Trials using Bifidobacterium species or Saccharomyces boulardii showed no beneficial effects.", "population_specificity": "Preterm infants (\u2264 34 weeks' gestation) and/or those with a birth weight \u22641500 g.", "effective_dosage": "Not specified", "study_duration": "Initiated within the first 7 days and continued for at least 14 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.656070+00:00"}
{"study_id": 196015, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to confirm previous conclusions on the effects of Probiotics through a meta-analysis of randomized clinical trials.", "results_summary": "The meta-analysis supported previous data linking Probiotics to its intended outcomes, though specific results are not detailed in the abstract.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:39.808806+00:00"}
{"study_id": 196009, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize existing studies on how dietary probiotic additives influence gut microbiota in various animals and clarify the contributions of different probiotics to intestinal microbiota.", "results_summary": "Probiotics modulate intestinal homeostasis, promote gut health, inhibit pathogenic bacteria, and support beneficial flora growth, with effects varying by probiotic species. The review highlights species-specific impacts of probiotics on gut microbiota in humans, mice, pigs, and chickens.", "population_specificity": "Humans, mice, pigs, and chickens.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:43.280832+00:00"}
{"study_id": 196019, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to identify probiotic strains, particularly Bifidobacteria and Lactobacillus, that could modulate immune responses and restore tolerance in systemic lupus erythematosus (SLE) patients.", "results_summary": "The study found that certain probiotic strains can regulate immune responses via tolerogenic mechanisms, modifying dysregulated mediators like dendritic cells, Treg cells, and cytokines (IL-6, IFN-\u03b3, IL-17, IL-23), potentially ameliorating immune responses in SLE.", "population_specificity": "Systemic lupus erythematosus (SLE) patients and general inflammatory/autoimmune disease contexts.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:44.001069+00:00"}
{"study_id": 196020, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotics supplementation significantly lowers blood cholesterol levels, specifically total cholesterol (TC) and low-density lipoprotein (LDL), in normo/hypercholesterolemic patients.", "results_summary": "The meta-analysis found that probiotics supplementation significantly reduced serum TC (-8.40 mg/dl) and LDL (-6.63 mg/dl) levels, suggesting a potential reduction in coronary heart disease risk. No significant effects were observed for high-density-lipoprotein-cholesterol or triglycerides.", "population_specificity": "606 normo/hypercholesterolemic patients from 12 randomized controlled trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:44.220185+00:00"}
{"study_id": 196017, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effect of probiotics as an adjuvant to sequential H. pylori eradication therapy on treatment outcome and patient compliance.", "results_summary": "The study found that probiotics significantly increased H. pylori eradication rates (86.8% vs. 70.8%) and reduced first-week diarrhea-related treatment discontinuation (1.88% vs. 12.26%) compared to the control groups. Probiotic use also improved treatment compliance without affecting antibiotic resistance.", "population_specificity": "159 patients with H. pylori infection receiving sequential eradication therapy.", "effective_dosage": "1 capsule/day of Bifidobacterium animalis subsp. lactis B94.", "study_duration": "2 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:44.612622+00:00"}
{"study_id": 196018, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether changes in adiposity after supplementation with Lactobacillus strains (L. curvatus HY7601 and L. plantarum KY1032) were associated with metabolic intermediates in overweight individuals.", "results_summary": "Probiotic supplementation significantly increased levels of medium-chain acylcarnitines (C8:1, C14:1, C10, C12:1) and was negatively associated with reductions in body weight, body fat percentage, body fat mass, and L1 subcutaneous fat area. The study suggests that probiotic-induced weight loss and adiposity reduction are linked to increased acylcarnitine levels.", "population_specificity": "66 non-diabetic, overweight individuals", "effective_dosage": "2 g of probiotic powder daily", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:45.246594+00:00"}
{"study_id": 196022, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of probiotics in preventing atopic eczema (AE) and their potential efficacy in treating AE.", "results_summary": "The study found that prenatal and postnatal intake of probiotics may help prevent AE, but there is little evidence to suggest a role in the treatment of AE.", "population_specificity": "Children and their families (prenatal and postnatal focus).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:46.366753+00:00"}
{"study_id": 196023, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of probiotic consumption on glycemic control in diabetic patients.", "results_summary": "Probiotic supplementation significantly decreased fasting blood glucose and hemoglobin A1c in diabetic patients, though the clinical response varied based on participant characteristics and probiotic type.", "population_specificity": "Diabetic patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:46.580975+00:00"}
{"study_id": 196024, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotic supplementation has a positive effect on psychological symptoms such as depression, anxiety, and perceived stress in healthy human volunteers.", "results_summary": "The meta-analysis found that probiotic supplementation resulted in a statistically significant improvement in psychological symptoms compared to placebo, with a standardized mean difference of 0.34 (95% CI 0.07-0.61). All included studies passed quality analysis, supporting the reliability of the findings.", "population_specificity": "Healthy human volunteers", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:48.601443+00:00"}
{"study_id": 196028, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to determine whether probiotics could reduce inflammation following strenuous exercise in resistance-trained men.", "results_summary": "The abstract does not provide specific results regarding the effects of probiotics on inflammation post-exercise.", "population_specificity": "15 healthy resistance-trained men", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:50.611812+00:00"}
{"study_id": 196026, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation could reduce the risk of fungal infection (Candida colonization and invasive fungal sepsis) in preterm neonates in NICUs.", "results_summary": "Probiotic supplementation was significantly associated with a lower risk of Candida colonization (RR 0.43, 95% CI 0.27-0.67, p=0.0002) based on meta-analysis of two RCTs involving 329 preterm neonates.", "population_specificity": "Preterm neonates in neonatal intensive care units (NICUs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:52.215376+00:00"}
{"study_id": 196030, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to systematically evaluate the impact of probiotic supplementation on anxiety and depression symptoms in humans by reviewing randomized controlled trials.", "results_summary": "The study found limited support for the use of some probiotics in reducing human anxiety and depression, with apparent psychological benefits detected despite methodological limitations and the complexity of gut-brain interactions.", "population_specificity": "Clinically diagnosed and non-clinical samples (4 and 6 trials, respectively).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:52.687786+00:00"}
{"study_id": 196027, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to evaluate whether an oral probiotic supplement (Lactobacillus rhamnosus GR-1 and L. reuteri RC-14) could maintain or restore normal vaginal microbiota during pregnancy.", "results_summary": "The study found no significant difference in the proportion of normal vaginal microbiota between the probiotic and placebo groups after intervention, suggesting the probiotics had no effect on vaginal health during mid-gestation.", "population_specificity": "Pregnant women (n=320 enrolled, 290 analyzed pre-intervention, 271 post-intervention).", "effective_dosage": "10^9 CFU of Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 (exact frequency not specified).", "study_duration": "Not explicitly stated in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:53.506326+00:00"}
{"study_id": 196029, "supplement_id": 1474, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to assess whether probiotic supplementation improves the efficacy and tolerability of Helicobacter pylori eradication therapy by analyzing randomized controlled trials.", "results_summary": "Probiotic supplementation significantly improved H. pylori eradication rates and reduced antibiotic-related side effects, particularly nausea, vomiting, diarrhea, and constipation. The benefits were consistent across different age groups, regions, and treatment durations, though some subgroups showed no significant reduction in adverse events.", "population_specificity": "2306 patients across 13 randomized controlled trials, including adults and children from Europe and Asia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Varied (7-day and 14-day treatment subgroups mentioned).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:54.031679+00:00"}
{"study_id": 196032, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of two multispecies probiotic formulations in treating IBS-C subjects and assess their impact on gut microbiota composition.", "results_summary": "Probiotic groups showed higher responder rates for symptom improvement compared to placebo, with effects maintained during follow-up. Fecal analysis confirmed increased probiotic levels in treated groups but not in the placebo group.", "population_specificity": "150 subjects diagnosed with IBS-C (irritable bowel syndrome with constipation).", "effective_dosage": "Daily oral administration (specific amounts not detailed).", "study_duration": "60 days of treatment, with follow-up at 90 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:54.862525+00:00"}
{"study_id": 196033, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to test the effects of a multispecies probiotic on innate immune function, bacterial translocation, and gut permeability in patients with liver cirrhosis.", "results_summary": "Probiotic supplementation significantly increased serum neopterin levels and neutrophil reactive oxygen species production but had minimal influence on gut barrier function, bacterial translocation, or inflammatory markers. Liver function showed some improvement with probiotics, though severe infections occurred in both groups, mostly after the intervention ended.", "population_specificity": "Stable cirrhotic out-patients", "effective_dosage": "Daily dose of a probiotic powder containing eight different bacterial strains (Ecologic Barrier, Winclove, Amsterdam, The Netherlands)", "study_duration": "6 months of intervention, followed by 6 months of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:56.141181+00:00"}
{"study_id": 196035, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic and preventive effects of probiotics in rheumatoid arthritis (RA) and their potential as an adjuvant therapy.", "results_summary": "The study found that specific probiotics supplementation demonstrated anti-inflammatory effects, improved daily activities, and alleviated symptoms in RA patients, suggesting probiotics may be a promising adjuvant treatment option.", "population_specificity": "Patients with rheumatoid arthritis (RA).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:57.965191+00:00"}
{"study_id": 196034, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of probiotic and synbiotic consumption on fasting blood glucose (FBG) levels in adults.", "results_summary": "The meta-analysis found a borderline statistically significant reduction in FBG (-0.18 mmol/L) overall, with more pronounced effects in adults with high baseline FBG (\u22657 mmol/L) and those taking multispecies probiotics. Neither probiotics nor synbiotics alone showed significant reductions in FBG.", "population_specificity": "Adults with varying baseline FBG levels, including those with high FBG (\u22657 mmol/L).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:59.131935+00:00"}
{"study_id": 196036, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the safety and efficacy of probiotic supplementation in children with cystic fibrosis, focusing on pulmonary exacerbations, gastrointestinal symptoms, and gut microbial balance.", "results_summary": "Probiotic supplementation significantly reduced pulmonary exacerbation rates and fecal calprotectin levels, improved gastrointestinal symptoms, and enhanced gut microbial balance, though the evidence was of low quality.", "population_specificity": "Children with cystic fibrosis (N = 275 across nine studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:03:59.634156+00:00"}
{"study_id": 196041, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers examined whether probiotics could reduce the incidence of gestational diabetes mellitus (GDM).", "results_summary": "Supplementation with probiotics reduced the incidence of GDM, but confirmatory studies are still needed. The abstract does not provide detailed statistical outcomes or effect sizes.", "population_specificity": "Pregnant women, particularly those with obesity or at risk for GDM.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:01.125708+00:00"}
{"study_id": 196040, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of probiotic supplementation on metabolic profiles in individuals with Type 2 diabetes mellitus (T2DM).", "results_summary": "Probiotics significantly reduced fasting blood glucose (FBG) and increased high-density lipoprotein-cholesterol (HDL-C), but showed no significant effects on LDL-C, total cholesterol, triglycerides, HbA1c, or HOMA-IR.", "population_specificity": "Individuals with Type 2 diabetes mellitus (T2DM).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:01.609493+00:00"}
{"study_id": 196037, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine the pharmacologically effective dose of B. infantis required to achieve predominant gut colonization in healthy breastfed infants at 6 weeks of age.", "results_summary": "The study proposed a phase I trial to identify the dose of B. infantis needed for predominant gut colonization, with the goal of informing future efficacy trials for preventing atopic dermatitis and food allergies. Results from the trial were not provided in the abstract.", "population_specificity": "Healthy breastfed infants", "effective_dosage": "Two doses administered on days 7 and 14 of life (specific amounts not detailed in the abstract)", "study_duration": "Intervention administered over two weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:01.638580+00:00"}
{"study_id": 196042, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the efficacy of probiotic supplementation on intestinal transit time (ITT) in adults and identify factors influencing these outcomes.", "results_summary": "Probiotic supplementation moderately reduced ITT, with greater efficacy in constipated subjects, high-quality studies, and specific strains like B. lactis HN019 and DN-173 010. Other strains showed negligible effects.", "population_specificity": "Adults, with subgroup analysis for constipated vs. non-constipated individuals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:03.122518+00:00"}
{"study_id": 196043, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of probiotic supplementation (Vivomixx\u00ae) on gastrointestinal symptoms, core deficits of ASD, cognitive and language development, brain function, and urinary phthalate levels in children with autism spectrum disorders.", "results_summary": "The abstract does not provide results, as the study appears to be ongoing or not yet concluded at the time of the abstract's publication.", "population_specificity": "Preschoolers with Autism Spectrum Disorders (ASD), divided into GI and Non-GI groups based on symptom severity.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:04.823647+00:00"}
{"study_id": 196044, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a dual-coated probiotic supplement (Duolac Care) could improve symptoms of diarrhea-predominant irritable bowel syndrome compared to non-coated probiotics.", "results_summary": "The dual-coated probiotic group showed significant improvement in overall discomfort and better stool consistency compared to the non-coated group, possibly due to changes in intestinal microbiota, particularly Bifidobacterium levels.", "population_specificity": "Fifty subjects with diarrhea-predominant irritable bowel syndrome.", "effective_dosage": "Two capsules per day, each containing 5 billion bacteria.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:06.175345+00:00"}
{"study_id": 196046, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to systematically review the evidence for probiotic supplementation's effect on fecal microbiota composition in healthy adults using high-throughput molecular approaches.", "results_summary": "The review found no significant effects of probiotics on fecal microbiota composition in terms of \u03b1-diversity, richness, or evenness, with only one study showing a modification in \u03b2-diversity compared to placebo. The overall conclusion was a lack of evidence for probiotics impacting microbiota in healthy adults.", "population_specificity": "Healthy adults", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:08.160088+00:00"}
{"study_id": 196045, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 65, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether supplementation with Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011 could reduce antibiotic-associated diarrhoea in healthy adults.", "results_summary": "The study found no significant differences in primary outcomes (bowel movement consistency and frequency) between probiotic and placebo groups. However, a post hoc analysis showed probiotics reduced the duration of diarrhoea-like defecations by one day compared to placebo.", "population_specificity": "Healthy adults receiving antibiotics (amoxicillin-clavulanic acid).", "effective_dosage": "8\u00d710^9 colony-forming units of a multi-strain probiotic daily.", "study_duration": "1 week during antibiotic use and 1 week post-antibiotic.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:08.673266+00:00"}
{"study_id": 196047, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to assess the effects of maternal probiotic/synbiotic supplementation during lactation on long-term health outcomes in infants, such as overweight/obesity or metabolic syndrome.", "results_summary": "Two studies evaluated the effects of maternal probiotic/synbiotic supplementation on infant health outcomes, but the abstract does not specify the nature or significance of these effects. The overall literature on this topic was found to be scarce.", "population_specificity": "Lactating women and their infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:09.924336+00:00"}
{"study_id": 196049, "supplement_id": 1474, "safety_score": "100", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of probiotic supplementation in improving chronic pulmonary symptoms in individuals exposed to sulfur mustard.", "results_summary": "The probiotic group showed significant improvements in FEV1/FVC and a notable decrease in CAT scores compared to the placebo group, with no reported adverse events.", "population_specificity": "65 subjects suffering from chronic pulmonary complications due to sulfur mustard exposure.", "effective_dosage": "1 capsule (1 \u00d7 10^X CFU, exact dosage not specified in abstract).", "study_duration": "Not specified in abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:09.959222+00:00"}
{"study_id": 196048, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether long-term Lactobacillus rhamnosus GG intake influences antibiotic use, antibiotic-associated gastrointestinal complaints, and intestinal microbiota composition in preschool children.", "results_summary": "Long-term L. rhamnosus GG supplementation altered intestinal microbiota composition (increasing Prevotella, Lactococcus, and Ruminococcus while decreasing Escherichia) and reduced gastrointestinal complaints after macrolide use. It also appeared to prevent some penicillin-associated microbiota changes and reduced antibiotic use for bacterial infections up to 3 years post-trial.", "population_specificity": "Preschool children aged 2-7 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Long-term (exact duration not specified in the abstract).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:11.003271+00:00"}
{"study_id": 196050, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the impact of probiotics and synbiotics on the incidence of postoperative sepsis in gastrointestinal surgical patients.", "results_summary": "Probiotic and synbiotic use significantly reduced the risk of postoperative sepsis by 38% (RR = 0.62, 95% CI 0.52-0.74, p < 0.001). The study concluded that probiotic/synbiotic supplementation is a valuable adjunct in the care of GI surgery patients.", "population_specificity": "Gastrointestinal (GI) surgical patients undergoing elective surgery.", "effective_dosage": "Not specified (any strain or dose was included).", "study_duration": "Outcomes assessed within 1 month of surgery.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:11.651703+00:00"}
{"study_id": 196052, "supplement_id": 1474, "safety_score": "80", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotic supplementation improves H. pylori eradication rates when combined with standard therapy.", "results_summary": "The study found that probiotics did not significantly improve H. pylori eradication rates compared to placebo, but they did reduce adverse effects like diarrhea and nausea. No improvement was observed when probiotics were combined with triple therapy over a 14-day course.", "population_specificity": "Patients undergoing H. pylori eradication therapy.", "effective_dosage": "Not specified", "study_duration": "14 days (for triple therapy combination)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:14.336067+00:00"}
{"study_id": 196051, "supplement_id": 1474, "safety_score": "75", "efficacy_score": 68, "quality_score": 82, "study_goal": "The researchers aimed to evaluate the role of probiotics, particularly Lactobacillus, Bifidobacterium, and Saccharomyces, as adjuncts to antibiotics for the treatment of Helicobacter pylori infection.", "results_summary": "Probiotic monotherapy reduced H. pylori density by 2.0%-64.0% and achieved eradication in up to 32.5% of cases, though recrudescence was likely. As adjuvants to antibiotics, probiotics increased treatment efficacy (OR 1.12-2.07) and reduced adverse effects, particularly diarrhea (OR 0.16-0.47).", "population_specificity": "Subjects with Helicobacter pylori infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:14.362649+00:00"}
{"study_id": 196054, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of early probiotic administration on gut microflora and feeding intolerance in pre-term infants.", "results_summary": "Probiotic supplementation significantly increased gut lactobacillus and bifidobacterium levels and reduced feeding intolerance rates in pre-term infants compared to the control group.", "population_specificity": "Hospitalized pre-term infants", "effective_dosage": "Not specified", "study_duration": "2 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:15.717954+00:00"}
{"study_id": 196053, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of multi-strain probiotics on glycemic control and other diabetes-related outcomes in people with type 2 diabetes.", "results_summary": "Probiotics modestly improved HbA1c and fasting insulin levels in participants with type 2 diabetes, with significant changes observed in per-protocol analysis but not in intention-to-treat analysis. Secondary outcomes did not show significant changes.", "population_specificity": "136 participants with type 2 diabetes, aged 30-70 years.", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:16.044891+00:00"}
{"study_id": 196056, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine whether enteral probiotic supplementation reduces the risk of late-onset sepsis (LOS) in preterm neonates in neonatal intensive care units.", "results_summary": "Probiotic supplementation significantly reduced the risk of any sepsis, bacterial sepsis, and fungal sepsis in preterm neonates, particularly in very low birth weight infants (<1500 g), but not in extremely low birth weight infants (<1000 g). No systemic infections caused by probiotic organisms were reported.", "population_specificity": "Preterm neonates in neonatal intensive care units, including very low birth weight (<1500 g) and extremely low birth weight (<1000 g) infants.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:18.755504+00:00"}
{"study_id": 196057, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether prenatal and/or postnatal probiotic supplementation could reduce the risk of atopy and food hypersensitivity in young children.", "results_summary": "Probiotics administered both prenatally and postnatally reduced the risk of atopy (RR 0.78) and food hypersensitivity (RR 0.77), but no effects were observed when administered only prenatally or postnatally. The long-term effects remain undefined.", "population_specificity": "Infants and pregnant mothers (2947 infants across 17 trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:19.630968+00:00"}
{"study_id": 196058, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to examine the effect of oral administration of Saccharomyces boulardii and mode of delivery on the intestinal microbial community in preterm infants.", "results_summary": "The study found changes in microbial community composition over time, with increased bacterial diversity at 2 and 6 weeks compared to baseline. Actinobacteria and Bacteroidetes increased in abundance, particularly in vaginally delivered infants, but the study lacked statistical power to confirm probiotic effects.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:19.699019+00:00"}
{"study_id": 196055, "supplement_id": 1474, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and efficacy of Saccharomyces boulardii CNCM I-745 in improving weight gain, feeding tolerance, and preventing necrotizing enterocolitis and sepsis in preterm infants.", "results_summary": "The probiotic group showed significantly higher weight gain and formula intake, reached full enteral feeding faster, and had no cases of necrotizing enterocolitis or adverse effects. No significant difference in sepsis was observed.", "population_specificity": "Preterm infants with gestational age 30-37 weeks and birth weight 1500-2500g.", "effective_dosage": "50mg/kg twice daily.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:20.155094+00:00"}
{"study_id": 196060, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of probiotics on glucose and glycaemic factors in individuals with diabetes and associated risk factors.", "results_summary": "Probiotics significantly reduced glucose and HbA1c levels but did not show significant effects on insulin or HOMA-IR. The effects were more pronounced in participants with diabetes compared to those with other risk factors.", "population_specificity": "Individuals with diabetes and associated risk factors (614 subjects across 11 studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:21.800390+00:00"}
{"study_id": 196059, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine whether probiotic supplementation reduces the risk of late-onset sepsis (LOS) in preterm infants by conducting a systematic review of randomized controlled trials.", "results_summary": "Pooled results from 37 RCTs (N = 9416) showed that probiotics significantly decreased the risk of LOS (13.9% vs. 16.3%, relative risk 0.86, P = .0007). The effect remained significant even after excluding studies with high risk of bias.", "population_specificity": "Preterm infants", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:22.269908+00:00"}
{"study_id": 196061, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the scientific evidence supporting the use of probiotics as a complementary and alternative medicine (CAM) treatment for otitis media (OM) in children.", "results_summary": "The abstract does not provide specific findings on probiotics, but it notes that CAM therapies, including probiotics, lack sufficient scientific evidence to be considered potential treatments for OM. Further studies are needed to assess their efficacy.", "population_specificity": "Children with otitis media (OM).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:23.621396+00:00"}
{"study_id": 196062, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential antiobesity effects of probiotics, specifically Lactobacillus and Bifidobacterium strains, and their impact on metabolic and inflammatory markers.", "results_summary": "Animal studies showed reductions in weight gain and fat tissue mass, along with improvements in lipid profiles, glucose tolerance, and inflammatory markers. Human studies were limited, making it premature to judge efficacy due to strain-specific effects and individual variability.", "population_specificity": "Primarily animal models (dietary-induced obesity); limited human studies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:24.171211+00:00"}
{"study_id": 196063, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the effect of a probiotic supplement on glucose metabolism indices and weight changes in women with newly diagnosed gestational diabetes mellitus (GDM).", "results_summary": "The probiotic group showed significantly lower weight gain in the last 2 weeks and greater reductions in fasting blood sugar compared to placebo. Insulin resistance decreased in the probiotic group but increased slightly in the placebo group, though the change in placebo was not statistically significant.", "population_specificity": "Pregnant women with newly diagnosed GDM (n=64).", "effective_dosage": "Not specified in the abstract.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:27.114429+00:00"}
{"study_id": 196064, "supplement_id": 1474, "safety_score": "60", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to assess the therapeutic effects of two probiotic strains, Lactobacillus rhamnosus NutRes 1 and Bifidobacterium breve NutRes 204, on a chronic murine colitis model induced by dextran sodium sulphate (DSS).", "results_summary": "L. rhamnosus improved DSS-induced bloody diarrhea during the resolution phase but worsened fecal condition after colitis re-induction, accompanied by reduced neutrophils and increased pro-inflammatory markers. B. breve showed no significant benefits.", "population_specificity": "DSS-induced chronic colitis murine model (mice).", "effective_dosage": "Not specified.", "study_duration": "Probiotic supplementation started during the resolution phase after the first DSS cycle and continued until the end of the experiment.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:28.541956+00:00"}
{"study_id": 196066, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess the effects of prophylactic probiotics in preterm infants, focusing on outcomes like necrotizing enterocolitis (NEC), mortality, and sepsis.", "results_summary": "Probiotic supplementation significantly reduced the incidence of NEC (RR = 0.55) and mortality (RR = 0.72) in preterm infants, with no significant difference in sepsis rates (RR = 0.86). The effect sizes were comparable to those found in RCT meta-analyses.", "population_specificity": "Preterm infants under 37 weeks of gestational age.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:28.760184+00:00"}
{"study_id": 196065, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 80, "quality_score": 90, "study_goal": "The researchers aimed to determine if oral probiotics (prOVag\u00ae) combined with standard metronidazole or targeted antibiotic treatment could reduce recurrence rates of bacterial vaginosis (BV) and aerobic vaginitis (AV).", "results_summary": "Probiotic use significantly delayed clinical relapse of BV/AV symptoms (up to 51% for BV and 76% for AV), reduced vaginal pH and Nugent score, and increased vaginal Lactobacillus counts compared to placebo.", "population_specificity": "18-50-year-old women with recurrent BV/AV in Poland.", "effective_dosage": "One capsule twice daily for 10 days with antibiotics, then one capsule daily for 10 days perimenstrually during follow-up.", "study_duration": "Multiple follow-up visits over several months (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:29.445417+00:00"}
{"study_id": 196067, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and feasibility of administering Lactobacillus plantarum (LBP) to children and adolescents undergoing allogeneic hematopoietic cell transplantation (HCT).", "results_summary": "The study found that LBP administration was feasible, with 97% compliance, and no cases of LBP bacteremia or unexpected adverse events were observed. The results suggest LBP is safe and feasible for use in this population.", "population_specificity": "Children and adolescents undergoing allogeneic HCT.", "effective_dosage": "Once-daily supplementation (specific dosage not mentioned).", "study_duration": "From day -8 or -7 until day +14 (approximately 22-23 days).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:30.856614+00:00"}
{"study_id": 196069, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to systematically review the effect of probiotic supplementation (PS) in preventing invasive fungal infections (IFI) and fungal gut colonization in preterm neonates.", "results_summary": "Meta-analysis showed PS reduced IFI risk in a fixed effects model (RR: 0.50), but results were not significant in a random effects model (RR: 0.64). Excluding a study with high baseline IFI incidence eliminated significant benefits. Three of five studies reported reduced fungal gut colonization, while two did not.", "population_specificity": "Preterm neonates born before 37 weeks of gestation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:30.882053+00:00"}
{"study_id": 196071, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the ability of probiotics to modify selected cardiometabolic risk factors in subjects with type 2 diabetes.", "results_summary": "The meta-analysis showed a significant effect of probiotics on reducing HbA1c levels and HOMA-IR, but no significant effect on FPG, insulin, CRP levels, or lipid profile.", "population_specificity": "Subjects with type 2 diabetes", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:31.897910+00:00"}
{"study_id": 196070, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether specific probiotic strains (e.g., S. boulardii, L. johnsonni La1, L. reuteri, L. GG) could inhibit H. pylori, reduce antibiotic-associated side effects, and improve eradication rates in H. pylori treatment.", "results_summary": "The study found that certain probiotics, particularly S. boulardii and L. johnsonni La1, could reduce H. pylori bacterial load but not fully eradicate it. Probiotics like S. boulardii, L. reuteri, and L. GG also decreased gastrointestinal side effects from antibiotic therapy, potentially improving eradication rates.", "population_specificity": "Patients undergoing standard H. pylori eradication treatment (antibiotics and proton pump inhibitors).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:33.416436+00:00"}
{"study_id": 196072, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects of probiotic supplementation on glycemic and inflammatory indices in patients with nonalcoholic fatty liver disease (NAFLD).", "results_summary": "Probiotic supplementation significantly reduced fasting blood sugar, insulin, insulin resistance, and interleukin-6 (IL-6) in NAFLD patients, though tumor necrosis factor alpha (TNF-\u03b1) was not significantly affected. The study concluded that probiotics could be beneficial as a complementary therapy for NAFLD.", "population_specificity": "42 patients with NAFLD referred to a gastroenterology clinic.", "effective_dosage": "2 capsules/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:35.596006+00:00"}
{"study_id": 196073, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether probiotic supplementation could mitigate antibiotic-induced alterations in gut microbiota during H. pylori eradication therapy.", "results_summary": "Probiotic supplementation reduced the antibiotic-induced changes in gut microbiota composition, particularly limiting the increase in Proteobacteria and antibiotic-resistant bacteria compared to the antibiotics-only group.", "population_specificity": "Subjects undergoing H. pylori eradication therapy (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:36.190992+00:00"}
{"study_id": 196074, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effect of Bifidobacterium animalis subsp. lactis, BB-12\u00ae, on defecation frequency and gastrointestinal well-being in healthy adults with low defecation frequency and abdominal discomfort.", "results_summary": "The study found that BB-12\u00ae significantly increased defecation frequency compared to placebo, with effects similar across tested doses (1 or 10 billion CFU/day). However, no significant improvement was observed in overall GI well-being.", "population_specificity": "Healthy adults with low defecation frequency and abdominal discomfort.", "effective_dosage": "1 or 10 billion colony-forming units (CFU) per day.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:37.846856+00:00"}
{"study_id": 196077, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to evaluate whether maternal probiotic supplementation could provide protective effects against childhood asthma.", "results_summary": "The study found that trials of maternal probiotic supplementation did not show consistent protective effects against asthma in children. The results were inconclusive and lacked uniformity across studies.", "population_specificity": "Pregnant women and their offspring (focus on childhood asthma prevention).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:37.891952+00:00"}
{"study_id": 196076, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if supplementing cART with probiotics could improve GI tract immunity and reduce inflammation in HIV-infected individuals.", "results_summary": "Probiotic supplementation significantly reduced immune activation markers (CD38, HLA-DR), microbial translocation markers (LBP), and inflammation (hsCRP) in HIV-positive patients, bringing levels comparable to controls.", "population_specificity": "20 HIV-infected humans on cART and 11 HIV seronegative controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:38.512181+00:00"}
{"study_id": 196075, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 60, "quality_score": 90, "study_goal": "The researchers aimed to assess the long-term effects of perinatal probiotic supplementation on gut microbiota composition and diversity in high-risk infants for atopic disease.", "results_summary": "Probiotic supplementation resulted in minor, short-term differences in microbiota composition during the intervention period, but no long-lasting effects were observed. Gut microbiota development continued similarly in both groups, evolving toward an adult-like configuration by age six.", "population_specificity": "Infants at high-risk for atopic disease, from birth to six years of age.", "effective_dosage": "Probiotic mixture (B. bifidum W23, B. lactis W52, Lc. Lactis W58) administered to pregnant women during the last 6 weeks of pregnancy and to their offspring during the first year of life (specific dosage not detailed).", "study_duration": "Supplementation during the last 6 weeks of pregnancy and the first year of life; follow-up until six years of age.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:42.257581+00:00"}
{"study_id": 196080, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of probiotics on the incidence of necrotizing enterocolitis (NEC) and related complications in very-low-birth-weight (VLBW) infants.", "results_summary": "Probiotic supplementation significantly reduced the risk of NEC by 49.1% and overall mortality by 26.9% in VLBW infants, with a modest reduction in sepsis and a shorter time to reach full enteral feeds.", "population_specificity": "Preterm very-low-birth-weight (VLBW) infants.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:42.264820+00:00"}
{"study_id": 196082, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to evaluate the role of probiotics in managing malnutrition in patients with end-stage liver disease and hepatic encephalopathy.", "results_summary": "The study suggests that probiotics, along with other dietary supplements, should be considered on a case-by-case basis for patients with cirrhosis, but does not provide specific efficacy data.", "population_specificity": "Patients with end-stage liver disease and hepatic encephalopathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:43.495453+00:00"}
{"study_id": 196081, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of probiotic supplementation during pregnancy and early infancy in preventing atopic diseases, particularly eczema, asthma, wheezing, and rhinoconjunctivitis.", "results_summary": "Probiotic supplementation significantly reduced the risk of infantile eczema (RR 0.78), especially with mixed probiotics (RR 0.54), but showed no significant effect on asthma, wheezing, or rhinoconjunctivitis.", "population_specificity": "Pregnant women and infants (4,755 children total, split into probiotic and control groups).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:43.900151+00:00"}
{"study_id": 196083, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of probiotics in preventing antibiotic-associated diarrhoea in care home residents.", "results_summary": "The abstract does not report specific findings on the effects of probiotics but highlights significant challenges in setting up the clinical trial, including regulatory barriers related to classifying probiotics as an investigational medicinal product.", "population_specificity": "Older adults residing in care homes in Wales.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:45.080281+00:00"}
{"study_id": 196079, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 30, "quality_score": 85, "study_goal": "The researchers aimed to evaluate postnatal growth in preterm infants receiving different probiotic supplements and assess the safety of probiotic administration.", "results_summary": "The study found no statistically significant differences in postnatal growth, body composition, or incidence of necrotizing enterocolitis and late-onset sepsis between preterm infants receiving probiotics and those receiving placebo. No adverse effects were associated with probiotic administration.", "population_specificity": "Preterm infants with a mean gestational age of 29.1 weeks and mean birth weight of 1173 g.", "effective_dosage": "Daily supplementation over 4-6 weeks (specific dosage not mentioned).", "study_duration": "4-6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:45.273690+00:00"}
{"study_id": 196084, "supplement_id": 1474, "safety_score": "85", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to assess the effect of the probiotic VSL#3 in preventing neonatal sepsis in low birthweight infants.", "results_summary": "The study found a non-significant 21% reduction in the risk of neonatal sepsis with VSL#3, reduced median hospitalization days (3 vs. 6 days), but no significant reduction in hospitalization risk. The onset of possible serious bacterial infection was delayed in the probiotics group.", "population_specificity": "Low birthweight infants aged 3-7 days in rural India.", "effective_dosage": "10 billion colony-forming units (cfu) daily.", "study_duration": "30 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:46.154964+00:00"}
{"study_id": 196088, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether probiotics could reduce the incidence of gestational diabetes mellitus (GDM) in at-risk populations.", "results_summary": "The study found that probiotic treatment was one of only four interventions that showed a reduction in the proportion of women developing GDM, though these results were not replicated in other trials. The abstract suggests that probiotics may be effective but highlights the need for further replication and improved study designs.", "population_specificity": "Women at risk of or diagnosed with gestational diabetes mellitus (GDM).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:51.648286+00:00"}
{"study_id": 196087, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of probiotics to improve histopathological features induced by H. pylori infection in the gastric antrum and corpus.", "results_summary": "Probiotics reduced H. pylori density at the luminal epithelium, improved histological inflammatory and activity scores in both gastric corpus and antrum, and demonstrated long-term effects post-discontinuation, likely via an immune mechanism. These findings suggest probiotics may lower the risk of severe gastritis, peptic ulcers, and progression to atrophic gastritis or gastric adenocarcinoma.", "population_specificity": "Patients with H. pylori-induced gastritis (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Long-term effects noted after discontinuation, but exact intervention duration not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:52.306888+00:00"}
{"study_id": 196086, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effect of probiotic strains Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on triglyceride and apolipoprotein A-V levels in hypertriglyceridemic subjects.", "results_summary": "The probiotic group showed an 18.3% reduction in triglycerides, a 21.1% increase in apo A-V, and a 15.6% increase in LDL particle size compared to placebo, with statistically significant results. The effects were more pronounced in subjects with higher baseline triglyceride levels, regardless of APOA5 genotype.", "population_specificity": "128 non-diabetic subjects with hypertriglyceridemia.", "effective_dosage": "2 g/day of powdered supplement containing L. curvatus HY7601 and L. plantarum KY1032.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:52.662101+00:00"}
{"study_id": 196089, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of probiotics to modulate immune responses and improve the performance of oral vaccines, particularly in developing countries.", "results_summary": "Probiotics showed modulatory effects on intestinal and systemic immune responses in animal models, but human studies have been small with varying results by age, antigen, and probiotic strain. Anthelminthic drugs may enhance immunogenicity of oral cholera vaccines, supporting microbiome modulation as a strategy.", "population_specificity": "Children and adults in developing countries (contextual focus, not specific study population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:04:53.193172+00:00"}
{"study_id": 196094, "supplement_id": 1474, "safety_score": "90", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to assess the feasibility, clinical efficacy, and adverse reactions of probiotic treatment in reducing migraine frequency and intensity in patients.", "results_summary": "The study found a significant reduction in migraine days per month and intensity, along with improved MIDAS scores, though HDI scores did not change significantly. Compliance was high, and adverse reactions were minimal and temporary.", "population_specificity": "29 migraine patients (27 completed the study).", "effective_dosage": "2 g/d of Ecologic\u00ae Barrier (2.5\u00d710^9 cfu/g).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:01.158615+00:00"}
{"study_id": 196093, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of probiotic yogurt and multispecies probiotic capsules on mental health and hypothalamic-pituitary-adrenal axis function in petrochemical workers.", "results_summary": "Probiotic yogurt and probiotic capsules significantly improved mental health parameters (GHQ and DASS scores) compared to conventional yogurt, with no significant improvements observed in the control group.", "population_specificity": "Petrochemical workers", "effective_dosage": "100 g/day probiotic yogurt + one placebo capsule or one probiotic capsule daily + 100 g/day conventional yogurt", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:03.308160+00:00"}
{"study_id": 196096, "supplement_id": 1474, "safety_score": "30", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the beneficial and harmful effects of probiotics as part of enteral nutrition formulations in patients with acute pancreatitis.", "results_summary": "The study found inconsistent and nearly contradictory results regarding probiotics, with one trial reporting increased serious adverse events, organ failure, and mortality, while post hoc analysis suggested reduced mortality, organ failure, and local septic complications with probiotics. The evidence was of very low quality, and findings do not support routine probiotic use in clinical practice.", "population_specificity": "Patients with acute pancreatitis.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:05.189576+00:00"}
{"study_id": 196095, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of Bifidobacterium longum BB536 supplementation on intestinal microbiota composition and immune response in term infants.", "results_summary": "BB536 supplementation increased bifidobacteria levels and the bifidobacteria/Enterobacteriaceae ratio at months 2 and 4, enhanced Th1 immune response (IFN-\u03b3 secretion) at 7 months, but did not affect antibody responses to vaccines.", "population_specificity": "300 healthy term infants (264 completed the study).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Intervention administered until at least 11 months of age (follow-up at months 2, 4, 7, and 11).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:05.669601+00:00"}
{"study_id": 196092, "supplement_id": 1474, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare salivary HNP1-3 levels between a group receiving probiotic supplementation (Lactobacillus paracasei SD1) and a control group, and to assess its impact on mutans streptococci (MS) counts and caries prevention.", "results_summary": "The probiotic group showed significantly higher salivary HNP1-3 levels at 3 and 6 months, reduced MS counts, and decreased pit and fissure caries increment, though no direct correlation was found between HNP1-3 levels and MS reduction.", "population_specificity": "60 schoolchildren (divided into intervention and control groups).", "effective_dosage": "Not specified", "study_duration": "12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T22:05:05.686706+00:00"}
